InvestorBrandNetwork (IBN) Content Platform

March 9, 2021 15:43:37

Green Hygienics Holdings (OTCQB: GRYN) is dedicated to delivering the highest operating standards of industrial hemp cultivation and processing, as well as the manufacturing of pharmaceutical-grade bioactive cannabinoids. GRYN, with a commitment to becoming the most highly certified hemp company in the industry, is poised to bring safe and consistent products to market and thus change the industry’s landscape and enhance consumer confidence. Green Hygienics achieved important milestones in 2020 that lie at the heart of its value proposition and pave a research-based innovation path to drive new product commercialization fully compliant to USDA and FDA regulatory requirements. A recent article discussed these accomplishments that include the company’s registration with the U.S. Food and Drug Administration, which enhances GRYN’s core mission to provide processing and product safety, transparency and reliability both to consumers and the pharmaceutical industry. In addition, GRYN received USDA Organic Certification (7 CFR Part 205) issued by the California Certified Organic Farmers. The certification allows the company to cultivate and process post-harvest industrial hemp and supply certified organic hemp products to national and international markets from its Sol Valley Ranch property.

To view the full article, visit https://cnw.fm/Fjv4I

About Green Hygienics Holdings Inc.

Green Hygienics Holdings is a California-based, innovative, technology-driven enterprise focused on the high-standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The company’s mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partnering with CPG (consumer-packaged-goods) and pharmaceutical companies. Green Hygienics intends to be a leader in compliances and capabilities in the hemp and cannabinoid supply marketplace. Using state-of-the-art technologies, the company intends to open a whole new world of novel cannabinoids and targeted bio-delivery technologies never before explored, solving the issues of stability, pharmacokinetics, biological tissue penetration, and bioavailability. Green Hygienics is building a team of visionary agrotechnology, pharmaceutical and life scientists working at the intersection of nutraceutical, cosmeceutical and pharmaceutical technologies with a goal to improve lives. For more information, please visit the Corporate Video Link and www.GreenHygienics.com.

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://cnw.fm/GRYN

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is part of the InvestorBrandNetwork.

Predictive Oncology Inc. (NASDAQ: POAI) Hits Milestone in AI Platform Development for Ovarian Cancer

March 9, 2021 15:30:08

Cancer screenings, treatments declined during COVID-19 pandemic, highlighting need for personalized therapies to improve outcomes
Comprehensive genomic, transcriptomic sequencing of patient samples complete, patient outcome data obtained from UPMC-Magee
Project is template for future partnerships with other healthcare institutions to expand POAI’s AI-driven clinical models to other cancers

The consequences of COVID-19 sent shock waves throughout the healthcare sector in more ways than just the direct impact of coronavirus infections. A recent study (https://ibn.fm/6LLiW) showed that cancer screenings and treatments declined during the pandemic, with the authors cautioning that the fallout could be dramatic. The study’s results certainly highlight the need for more individualized treatment regimens that improve patient outcomes, minimize patient visits and help patients with advanced disease at the time of treatment. This is the area of specialty of Predictive Oncology (NASDAQ: POAI), a knowledge-driven medicine company that focuses on applying data and artificial intelligence (“AI”) to cancer personalized medicine and drug discovery. Through its Helomics division, the Minneapolis-based company has just made a significant stride in its efforts to build AI-driven models of ovarian cancer by completing key data generation milestones in a retrospective study in collaboration with UPMC-Magee Women Hospital, an affiliate of the University of Pittsburgh Schools of the Health Sciences (https://ibn.fm/KSr2G).

While the science and technology are complex, the overarching concept isn’t: Test drugs on individual tumors in a lab setting to better inform doctors’ decisions in the real world. Effectively, Helomics performs chemotherapy on a patient’s tumor before the patient gets the drug to provide the oncologist with information on what may or may not work before the…

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork.

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Upsizes Its Bought Deal Offering Due to Surge in Demand

March 9, 2021 15:12:32

Cybin’s latest offering generated exceptional demand; announces upsize of “bought deal” offering
Burgeoning psychedelic sector attracts investors’ attention as compound may prove effective in mental health treatments.
Cybin appears set for rapid growth as research accelerates, public acceptance grows.

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotech company focused on psychedelic therapeutics for various psychiatric and neurological conditions, has announced that it has upsized the terms of its “bought deal” offering due to strong demand. The deal size, previously announced at CDN$20,025,000, has increased to aggregate gross proceeds of CDN$30,015,000 as the underwriters have agreed to purchase 13,340,000 units of the company at CDN$2.25 per unit. Cybin intends to use the net proceeds to further develop its clinical trials, novel molecule programs and technologies enhancing the patient experience as well as for working capital and general corporate purposes.

The announced upsize comes against the backdrop of a growing demand for psychedelic companies. The burgeoning sector is attracting increasing attention from investors with more companies going public and rapidly increased research sparking greater public acceptance and…

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]

PsychedelicNewsWire is part of the InvestorBrandNetwork.

Nextech AR Solutions Corp. (CSE: NTAR) (OTCQB: NEXCF) Is ‘One to Watch’

March 9, 2021 14:55:44

Nextech AR Solutions Corp. is a leading provider of web-based augmented reality for e-commerce, advertising and virtual events
The company provides businesses with a powerful end-to-end augmented reality platform designed specifically to increase online sales
Nextech AR’s current customer base includes the likes of Amazon, Johnson & Johnson, ViacomCBS, Toyota and Carnegie Mellon University
The company achieved record bookings in Q4 2020 of $7.3 million (estimated), marking a greater than 275% year-over-year increase
The Nextech AR management team has extensive experience stemming from time with a collection of Fortune 500 companies

Nextech AR Solutions (CSE: NTAR) (OTCQB: NEXCF), based in Vancouver, Canada, is a leading provider of web-based augmented reality for e-commerce, advertising and virtual events, with technology ranging from simple 3D images to using 360-degree videos. Nextech AR provides businesses with a powerful end-to-end augmented reality platform designed specifically to increase online sales.

The company is currently pursuing four unique verticals with its innovative technology, including…

NOTE TO INVESTORS: The latest news and updates relating to NEXCF are available in the company’s newsroom at https://ibn.fm/NEXCF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Sharing Services Global Corp. (SHRG) Continues to Build Leadership Team Well Equipped to Lead in Customer-Centric Era

March 9, 2021 14:39:16

Customer centricity key success factor for direct-sales growth
Consumers’ expectations are growing beyond products to include community built around larger purpose
SHRG brings direct-selling veteran ideally equipped to lead SHRG’s Elevacity division in today’s customer-centric environment

Customer centricity is rapidly becoming essential for the direct-selling industry. Sharing Services Global (OTCQB: SHRG), a diversified holding company specializing in direct selling and network marketing, appears poised to respond to the rising consumer expectation as it brings in an industry veteran to lead its Elevacity division.

Customer centricity involves constantly evolving business models as customer behavior and technology change. Consumers’ expectations are growing and today go beyond product features to include a larger purpose and a community of followers built around it. The change is critical for…

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Tesla Inc. (NASDAQ: TSLA) to Provide Technical Advice During Caledonian Nickel Mining

March 9, 2021 14:27:43

Last year, Tesla Inc. (NASDAQ: TSLA) CEO Elon Musk stated that he’d award a huge contract to any miner that could extract nickel in a way that was environmentally sustainable. Recently, Musk stated that his biggest concern was how to increase the supply of nickel, which is needed for electric vehicle (“EV”) batteries.

This is how Tesla came to be a technical adviser of a contentious nickel mine in New Caledonia. Last week, leaders in the French Pacific region decided to sell their stake in Vale to Prony Resources. Vale had been trying to find a buyer for the mine for more than a year, but the fact that New Caledonia…

NOTE TO INVESTORS: The latest news and updates relating to Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) are available in the company’s newsroom at http://ibn.fm/UUUU

About MiningNewsWire

MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is part of the InvestorBrandNetwork.

InvestorNewsBreaks – Sharing Services Global Corporation (SHRG) Well Equipped to Succeed in Fast-Changing Market

March 9, 2021 14:12:53

Sharing Services Global (OTCQB: SHRG), a diversified holding company specializing in the health and wellness direct-selling industry, is well-positioned to meet the requirements of the new era. An article on SHRG’s exploits and aspects of its operations that demonstrate its adaptability reads, “(in 2016) as many as 68% of Americans did not like online shopping because they were unable to see, touch or try on the products. However, since then, many aspects of consumer behavior have changed, spurring the movement of consumers to online shopping, including the latest push brought on by the pandemic.” SHRG, a direct-selling company, has positioned itself appropriately guided by the Blue Ocean Strategy. “The approach supports the company’s sales force, known as Elepreneurs, in efforts to target today’s consumers in a cost-efficient and direct approach, meeting requirements of a new era centered around social media and a widened consumer base… Since its wholly owned subsidiary Elepreneurs offers a complete virtual business – including a phone app, web system, and automated free sampling program – SHRG positions itself as a company fit for the new era where digital is becoming the norm.” To view the full article, visit https://ibn.fm/SLxum About Sharing Services Global Corporation Sharing Services Global Corporation, formerly Sharing Services Inc., is a publicly traded company dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies in the direct selling sector and other industries. The Sharing Services combined platform currently leverages the capabilities and expertise of various companies that market and sell products direct to the consumer through independent contractors. For more information, visit www.SHRGInc.com and www.TheHappyCo.com. NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office www.InvestorWire.com [email protected]

InvestorWire is part of the InvestorBrandNetwork.

InvestorNewsBreaks – The Very Good Food Company Inc. (CSE: VERY) (OTCQB: VRYYF) (FSE: 0SI) Executes Non-Binding Term Sheet for C$70M Credit Facility

March 9, 2021 14:02:07

The Very Good Food Company (CSE: VERY) (OTCQB: VRYYF) (FSE: 0SI) today announced that it has executed a non-binding term sheet with a prominent institutional lender for a committed C$70 million credit facility. Upon closing of the proposed financing, the company will have access to a senior secured C$20 million revolving line of credit and a C$50 million asset-backed term loan. “This proposed financing demonstrates VERY’s ability to access capital markets, with favorable terms, based on strong fundamentals,” said Mitchell Scott, CEO of The Very Good Food Company. “We believe this financing signals that our business plan and sector have major growth potential, which VERY is poised to execute upon to meet the existing and future demand for our products.”

To view the full press release, visit https://ibn.fm/wRdN2

About The Very Good Food Company Inc.

The Very Good Food Company is an emerging plant-based food technology company. Its mission is to use progressive food technology to create plant-based meat and other food products that are delicious while maintaining a wholesome nutritional profile. To date, the company has developed a core product line under The Very Good Butchers brand. For more information, visit www.VeryGoodButchers.com.

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) Announces Planned Name Change, Upcoming Meetings

March 9, 2021 13:50:06

Golden Leaf Holdings (CSE: GLH) (OTCQB: GLDFF), a premier, consumer-driven cannabis company specializing in retail, production, processing, wholesale, and distribution, plans to change its name to Chalice Brands Ltd. and will seek approval of the name change at is upcoming annual and special meeting (“AGM”); the meeting is slated for May 10, 2021, and will be held virtually. In addition to the name change, the company leadership team will request approval for a share consolidation intended to bring the common shares outstanding to approximately 65 million post the consolidation. The company anticipates approval and support for these requests, details of which will be mailed out later this month in the management information circular. In the announcement, the Company noted that during February there were conversion of principal amounts to equity of its convertible debentures due Nov. 16, 2022; the conversion totaled C$3,675,000 plus accrued interest. “Throughout this turnaround over the last 18 months, we continue to gather momentum and galvanize management behind the Chalice brand,” said Golden Leaf CEO Jeff Yapp in the press release. “Our Chalice Farms stores and our Chalice chews are the pride of our business. As we put the Golden Leaf era behind us, this name change serves to symbolize our resurgence as a relevant contender in the U.S. cannabis industry, driven by leadership in our home market of Oregon.

To view the full press release, visit https://cnw.fm/VRyZI

About Golden Leaf Holdings Ltd.

Golden Leaf Holdings is a premiere, consumer-driven cannabis company specializing in production, processing, wholesale, distribution and retail, with seven dispensaries in Portland, Oregon. The company is committed to developing a dynamic portfolio built around the recognized brands of Chalice Farms, with a focus on health and wellness. Markets served include Oregon, California, Nevada and Washington. For more information about this company, visit www.GoldenLeafHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to GLDFF are available in the company’s newsroom at https://cnw.fm/GLDFF

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is part of the InvestorBrandNetwork.

InvestorNewsBreaks – Clubhouse Media Group Inc. (CMGR) to Launch Major New Creator Hub in Dynamic Orlando Marketplace

March 9, 2021 13:35:47

Clubhouse Media Group (OTC: CMGR), an influencer-based marketing and media firm with a vast aggregate global social media reach, today announced its expansion into the dynamic and rapidly growing Orlando market with the upcoming launch of a new content creation Clubhouse location in Florida. According to the update, Clubhouse management believes the Florida market provides access to enormous upside in branding opportunities. Besides being the theme park capital of the world, Orlando also plays a central role in Florida’s massive tourism market and is growing at four times the rate of the United States and is the second fastest growing of the 30 largest cities in America. Orlando is also home of the Playlist Live annual convention, one of the most significant events of the year for the social media creator space. “With each expansion step, we push the growth ceiling higher by pushing into new markets, new demographics, and new branding opportunities,” said Chris Young, co-founder of Clubhouse Media Group. “Orlando is a dynamic and rapidly growing marketplace, with a huge international presence and massive ties to the theme park, live sports, resorts, recreation, and nightlife markets. It will also put Playlist right in our backyard.”

To view the full press release, visit https://ibn.fm/ijUSH

About Clubhouse Media Group Inc.

Clubhouse Media believes it represents the future of influencer media and marketing, with a global network of professionally run content houses, each of which has its own brand, influencer cohort and production capabilities. Clubhouse Media offers management, production and deal-making services to its handpicked influencers, a management division for individual influencer clients, and an investment arm for joint ventures and acquisitions for companies in the social media influencer space. Clubhouse Media’s management team consists of successful entrepreneurs with financial, legal, marketing, and digital content creation expertise. For more information, follow the company on Twitter: Twitter.com/ClubhouseCMGR?s=20

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

PsychedelicNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Enters Strategic LOI with ShroomBloom

March 9, 2021 13:22:20

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, today announced that it signed a letter of intent (“LOI”) with ShroomBloom Labs/Floja Bioscience Inc. to enter into an agreement for the supply of psychedelic mushroom biomass. British Columbia-based ShroomBloom is a mushroom cultivator leveraging a unique growing method that uses a sustainable forest product to grow organic Psilocybe Azurescens, also known as Azures, one of the most potent psilocybin mushrooms ever found. Under the terms of the LOI, Pure Extracts would be granted “most favoured nation” pricing and preferential access to ShroomBloom’s crop of psychedelic mushrooms. “A supply agreement with a world-class cultivator like ShroomBloom would ensure a reliable source of high-quality, high-potency, psychedelic mushroom biomass for our extraction facility so that we can produce plenty of psilocybin for our formulation R&D activities and for any resulting clinical trials,” said Pure Extracts CEO Ben Nikolaevsky.

To view the full press release, visit https://ibn.fm/1zzFU

About Pure Extracts Technologies Corp.

Pure Extracts features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available. On Sept. 25, 2020, Pure Extracts was granted its Standard Processing License by Health Canada under the Cannabis Act and the company’s stock began trading on the Canadian Securities Exchange (“CSE”) on Nov. 5, 2020. For more information, visit the company’s website at www.PureExtractsCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to PULL are available in the company’s newsroom at https://ibn.fm/PULL

About PsychedelicNewsWire

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]

PsychedelicNewsWire is part of the InvestorBrandNetwork.

GreenCarNewsBreaks – Ideanomics (NASDAQ: IDEX) Acquires 20% Stake in Energica Motor Company

March 9, 2021 13:04:55

Ideanomics (NASDAQ: IDEX) today announced that it has acquired 20% of Italian Energica Motor Company S.p.A., a developer of high-performance, 100% battery-powered motorbikes, for the consideration of $13.2 million. With this move, which marks continued investment in European-based OEM, Ideanomics expands its global footprint in the electric vehicle (“EV”) industry. “Energica has combined zero emissions EV technology with high-performance engineering synonymous with Italy’s Motor Valley to create a range of exceptional products for the motorcycle market,” said Alf Poor, CEO of Ideanomics. “It also has proprietary EV battery and DC fast-charging systems that have applications and synergies with Ideanomics Mobility. We are very impressed with Livia and her team, and we look forward to supporting them through their next phases of growth.”

To view the full press release, visit https://ibn.fm/iPJv0

About Ideanomics

Ideanomics is a global company focused on the convergence of financial services and industries experiencing technological disruption. The company’s Ideanomics Mobility division is a service provider that facilitates the adoption of electric vehicles by commercial fleet operators through offering vehicle procurement, finance and leasing, and energy management solutions under its innovative sales to financing to charging (“S2F2C”) business model. Ideanomics Capital is focused on disruptive fintech solutions for the financial services industry. Together, Ideanomics Mobility and Ideanomics Capital provide global customers and partners with leading technologies and services designed to improve transparency, efficiency and accountability, and the company’s shareholders with the opportunity to participate in high-potential, growth industries. Ideanomics is headquartered in New York, NY, with offices in Beijing, Hangzhou and Qingdao and operations in the U.S., China, Ukraine, and Malaysia. For more information, visit www.Ideanomics.com.

NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
[email protected]

Green Car Stocks is part of the InvestorBrandNetwork.

BioMedNewsBreaks – Healthy Extracts Inc. (HYEX) Releases FY 2020 Revenue Results, Year-End Accomplishments

March 9, 2021 12:49:28

Healthy Extracts (OTCQB: HYEX), a leading developer and manufacturer of heart health, brain health and supplementary technologies, has announced its year-end financial numbers and business updates for the 12-month period ending Dec. 31, 2020. Financial highlights of the report include revenue increases of 71% to $1,276,559 compared to 2019 revenues of $748,377 and a net shareholder equity increase of $3.7 million. In addition, the company eliminated all convertible debt. The report attributes the increases to Healthy Extracts transition to its new business of selling health-nutrition products. Business highlights for the year include a company name change, full reporting and upgrade to the OTCQB, the acquisition of Ultimate Brain Nutrients and the introduction of two key products: Clinical Immune and HerHeart. In addition, the company reported key progress on clinical studies and pilot studies focusing on its proprietary Fuel4Thought Brain Booster product, which is slated for release in Q2. “I am extremely excited about 2021 and our Live Life Young Again strategy,” said Healthy Extracts president Duke Pitts in the press release. “Our name and ticker symbol changes were finalized last week, transitioning to Healthy Extracts Inc., which aligns us with our corporate objectives. Our 2020 results demonstrate continued momentum for the company.”

To view the full press release, visit https://ibn.fm/gbaof

About Healthy Extracts Inc.

Healthy Extracts through its two subsidiaries, BergaMet NA and Ultimate Brain Nutrients (“UBN”), is engaged in proprietary research and development of natural plant-based formulations, as well as sales and distribution of natural-ingredient cardiovascular and neuro products. For more information about the company, please visit www.HealthyExtractsInc.com.

NOTE TO INVESTORS: The latest news and updates relating to HYEX are available in the company’s newsroom at https://ibn.fm/HYEX

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork

CryptoNewsBreaks – ISW Holdings Inc. (ISWH) Pays Off Major Convertible Note with Preemptive Payment, Preventing Dilution Risk

March 9, 2021 12:34:16

ISW Holdings (OTC: ISWH), a global brand management holdings company with commercial operations in telehealth and cryptocurrency mining, has paid off and cancelled a convertible debt note. The company announced that it had distributed $363,000 to settle the outstanding obligation, thereby removing it from the books. The note presented a dilution risk for shareholders, noted ISWH management, who reiterated that the company is committed to preventing dilution risk as part of its official anti-dilution strategic initiative, introduced last year. As part of that initiative, ISWH is regularly and consistently evaluating its financial situation and taking steps to eliminate, cancel or preempt dilution risks. Other strategic steps taken by ISWH leadership include moves to energize its initial POD5IVE crypto mining unit and gather the means to assemble and energize two additional mining pods. “As our financial reality has shifted over recent months, we have an opportunity to drive value for our shareholders in many ways, including eradicating dilution risk by being proactive in addressing outstanding liabilities,” said ISW Holdings president and chairman Alonzo Pierce in the press release. “Without this action, the note would have had the potential to convert at a 50% discount to current share pricing. We weren’t comfortable with that potential outcome, so we deployed capital to eliminate that risk. . . . This is just the beginning on so many levels, and we will continue to protect our shareholders and advance their interests around every corner. We are approaching every decision from the perspective of driving long-term value. We have a number of very exciting announcements coming as we continue to expand operations at a rapid rate, but we know that none of this would be possible without the steady, strong-handed support of our valued shareholders.”

To view the full press release, visit https://ccw.fm/E91Ei

About ISW Holdings Inc.

ISW Holdings, based in Nevada, is a diversified portfolio company comprised of essential business lines that serve consumer product demands. The company’s expertise lies in strategic brand development, early growth facilitation, as well as brand identity through its proprietary procurement process. Together with its partners, ISW Holdings seeks to provide a structure that meets large scalability demands, as well as anticipated marketplace needs. The company is able to meet these needs through a variety of strategic innovative processes. ISWH is creating and managing brands across a spectrum of disruptive industries. It maneuvers its proprietary companies through critical stages of market development, which includes conceptualization, go-to-market strategies, engineering, product integration and distribution efficiency. The company has also partnered with a well-known software development and consulting company, Bengala Technologies LLC, which is developing significant enhancements in the supply chain management space, and the partnership has a vitally needed patent now pending. For more information about the company, please visit www.ISWHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to ISWH are available in the company’s newsroom at http://ccw.fm/ISWH

About CryptoCurrencyWire (“CCW”)

CryptoCurrencyWire (CCW) is a financial news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with CCW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, CCW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CCW brings its clients unparalleled visibility, recognition and brand awareness.

To receive instant SMS alerts, text CRYPTO to 77948 (U.S. Mobile Phones Only)

CryptoCurrency News Wire is where News, content and information converge via Crypto.

For more information, please visit https://www.CryptoCurrencyWire.com

Please see full terms of use and disclaimers on the CryptoCurrencyWire (CCW) website applicable to all content provided by CCW, wherever published or re-published: http://CCW.fm/Disclaimer

CryptoCurrencyWire (CCW)
New York, New York
www.CryptoCurrencyWire.com
212.994.9818 Office
[email protected]

CryptoCurrencyWire is part of the InvestorBrandNetwork

BioMedNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports Q4, FY 2020 Numbers, Business Highlights

March 9, 2021 11:57:38

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has released its financial and business update report for the fourth quarter and full year 2020. The company reports significant progress across all aspects of its long-term strategic operating plan, including securing several accounts in the B2B (“B2B”) channel that are generating revenue and enrolling members and completing financing that provides capital to move forward on growth initiatives. In addition, DRIO’s acquisition of Upright allows the company to expand its digital therapeutics offering to include musculoskeletal. Other highlights included DRIO’s agreement to provide its digital therapeutics solution to eligible employees of the subsidiary of a U.S.-based Fortune 500 technology and engineering company and its agreement to provide its exclusive remote patient monitoring (“RPM”) solution to Presbyterian Medical Services, one of the largest integrated healthcare systems in New Mexico. The company also saw key additions made to its commercial management team and advisory board. In addition to releasing the report, Dario will host a simultaneous webcast and conference call to discuss the quarterly report. Interested parties can access the event by calling 877-451-6152 (domestic) and 201-389-0879 (international). A replay of the call can be accessed by dialing 844-512-2921 (domestic) or 412-317-6671 (international) and using the replay passcode 13716928. “The year 2020 was transformational for our company, as we made significant progress across all three pillars of growth: our transformation to a software as a service (SaaS) business model with high margin recurring revenues; our transition to a Business-to-Business-to-Consumer (B2B2C) focused digital therapeutics provider with larger member pools and lower customer acquisition costs; and the ongoing expansion of our product offering to manage multiple chronic conditions,” said Dario CEO Erez Raphael in the press release. “We won multiple contracts during the year that I believe validate our transition to B2B2C and provide a foundation for meaningful growth in 2021. We believe that our successful implementation and penetration of these contracts will contribute to growing revenue throughout 2021. . . . As we enter 2021, we have already launched, and are generating revenue from, all of the contracts that we have previously announced. Early enrollment has been robust and consistent with our expectations. We believe that these customer launches will contribute, along with anticipated additional contracts, to growing revenue in 2021 and beyond.”

To access a replay of the call, visit https://ibn.fm/8TtDD

To view the full press release, visit https://ibn.fm/mbdvZ

About DarioHealth Corp.

DarioHealth Corp. is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. Dario’s next-generation, AI-powered, digital therapeutic solutions support more than just an individual’s disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software and coaching to help individuals improve health and sustain meaningful outcomes. Dario offers one of the highest-rated diabetes and hypertension solutions on the market. The company’s cross-functional team operates at the intersection of life sciences, behavioral science, and software technology and is rapidly expanding into new chronic conditions and geographic markets, using a performance-based approach to improve its users’ health. Dario makes the right thing to do the easy thing to do. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork

MiningNewsBreaks – Asia Broadband Inc. (AABB) Announces Characteristics of Gold-Backed Crypto Token

March 9, 2021 11:37:54

Asia Broadband (OTC: AABB), a resource company focused on the production, supply and sale of precious and base metals, today specified the characteristics of the company’s AABB Gold (“AABBG”) cryptocurrency wallet and token developed by Core State Holdings Corp. (“CSHC”). According to the update, the AABBG token is backed 100% by physical gold held by the company in several high security, private locations in Mexico. AABB will continue to back the token 100% by additional physical gold acquired from future mining production and gold purchased from cash reserves or credit. The initial token release will be backed by $30 million in physical gold the company currently holds. At today’s gold price, the initial release will be approximately 5.5 million tokens at the one-tenth (0.1) gram of gold price for each AABBG token. The token price will also be tied to and supported by AABB at the market price of gold at a minimum. As the price of gold fluctuates, the minimum supported price of the AABBG token will increase or decrease, and the potential upside price of the token will be driven by market demand.

To view the full press release, visit https://ibn.fm/LdySi

About Asia Broadband Inc.

Asia Broadband is a resource company focused on the production, supply and sale of precious and base metals, primarily to Asian markets. The company utilizes its specific geographic expertise, experience and extensive industry contacts to facilitate its innovative distribution process from the production and supply of precious and base metals in Mexico to client sales networks in Asia. This vertical integration approach to sales transactions is the unique strength of AABB that differentiates the company and creates distinctive value for shareholders. The company is also releasing its freshly minted mine-to-token, gold-backed cryptocurrency AABB Gold token (“AABBG”) and expects to become a worldwide standard of exchange that is secured and trusted with gold backing, an outstanding quality relative to other cryptocurrencies. For more information, visit www.AsiaBroadbandInc.com.

NOTE TO INVESTORS: The latest news and updates relating to AABB are available in the company’s newsroom at https://ibn.fm/AABB

About MiningNewsWire

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is part of the InvestorBrandNetwork.

BioMedNewsBreaks – Brain Scientific Inc. (BRSF) Secures FDA Clearance for Next-Gen NeuroCap(TM)

March 9, 2021 11:06:05

Brain Scientific (OTCQB: BRSF), a neurology focused medical device and software company, today announced its receipt of U.S. Food and Drug Administration (“FDA”) 510(k) clearance for its next-generation NeuroCap(TM) device. NeuroCap is an advanced electroencephalogram (“EEG”) electrode array used to obtain rapid EEGs in routine clinical and research settings where recording of STAT EEGs is desired. “We are constantly working on new products for the EEG market. In the new version of NeuroCap, we added velcro strips for better adhesion. We also expanded the size range by adding an XS (extra small) size,” said Irina Nazarova, marketing director at Brain Scientific. “And now this device is designed for broader use — in addition to intensive care units and ERs.”

To view the full press release, visit https://ibn.fm/hpnQe

About Brain Scientific

Brain Scientific is a commercial-stage health care company with two FDA-cleared products, providing next-gen solutions to the neurology market. The company’s smart diagnostic devices and sensors simplify administration, shorten scan time and cut costs, allowing clinicians to make rapid decisions remotely and bridge the widening gap in access to neurological care. To learn more about the company’s corporate strategy, devices or for investor relations, visit www.BrainScientific.com.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork

MIT Scientists Develop Better Amputation Surgery to Improve Patients’ Outcomes

March 9, 2021 11:05:45

Researchers from MIT have developed an amputation surgery that can assist amputees to control their residual muscles better. The researchers say that this should help patients have better control of their prosthetic limbs while also reducing phantom limb pain.

Many muscles that are used to control the movement of an individual’s limbs occur in pairs, which alternately contract and stretch. When a limb is amputated using the conventional method, sensory feedback is cut off, and the movement of these muscles is restricted, which makes it even harder for amputees…

NOTE TO INVESTORS: The latest news and updates relating to Predictive Oncology (NASDAQ: POAI) are available in the company’s newsroom at http://ibn.fm/POAI

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork.

New Partnership Formed to Create Microneedle Patch to Deliver Psychedelic Medicines

March 9, 2021 11:05:22

Researchers from Terasaki Institute for Biomedical Innovation (“TIBI”) have designed a microneedle patch that will be used to deliver drugs and is currently being modified for use in micro-dosing psychedelic substances. These compounds include psilocybin mushrooms, LSD and MDMA, all of which have the potential to treat severe pain as well as mental health conditions such as depression and anxiety.

The microneedle patch, GeIMA, has been developed using a gelatinous substance, and its surface is made up of tiny microneedles that would contain the drug or drugs to beadministered to an individual. When the patch is applied to the skin, its microneedles pierce the epidermis…

NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) are available in the company’s newsroom at https://ibn.fm/PULL

About PsychedelicNewsWire

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]

PsychedelicNewsWire is part of the InvestorBrandNetwork.

Commercial Real Estate: The EV Sector Opportunity Hiding in Plain Sight

March 9, 2021 11:05:10

The nascent electric vehicle (“EV”) industry has presented an opportunity for sectors that weren’t traditionally associated with the automotive industry. Battery makers, for instance, are looking at a lucrative partnership with the EV sector for the foreseeable future, while tech companies such as Sony and Apple are slowly wading into the electric vehicle space as well. As demand for electric vehicles rises and green vehicles take over the roads, those in commercial real estate will be looking at a lucrative business opportunity: EV charging stations.

Unlike conventional vehicles, which run on gas-powered internal combustion engines, electric vehicles are powered by rechargeable lithium-ion batteries. At the moment, the U.S. Department of Energy has registered around 40,000 public charging stations to cater to the 1.6 million EVs on American roads. President Joe Biden has set an ambitious target to roll out 500,000 public EV charging stations by 2030, and as EVs start seeing widespread adoption, the demand for public charging…

NOTE TO INVESTORS: The latest news and updates relating to Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6A) (OTC: MOTNF) are available in the company’s newsroom at https://ibn.fm/MOTNF

About Green Car Stocks

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
[email protected]

Green Car Stocks is part of the InvestorBrandNetwork.

MiningNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) to Begin Commercial Recovery of Rare Earths in Coming Weeks

March 9, 2021 10:40:42

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading producer of uranium and critical minerals in the United States, today announced that the first shipments of natural monazite ore arrived this past weekend at the company’s White Mesa Mill in Blanding, Utah. According to the update, the material was separated by The Chemours Company at its Offerman Mineral Sand Plant in Georgia and transported by truck to the White Mesa Mill. In the coming weeks, Energy Fuels expects to gradually ramp-up production of an intermediate rare earth element (“REE”) product, called a “mixed REE carbonate,” which will then advance to REE separation, the next stage in the REE value chain. Energy Fuels also expects to recover the uranium in the ore, which will be used as fuel for the generation of clean, carbon-free nuclear energy. “Over the past few months, Energy Fuels, Neo and Chemours have quietly worked to create something very significant: a new, fully-integrated, U.S.- Europe rare earth supply chain. This weekend’s shipments of monazite ore from Chemours to Energy Fuels marks the beginning of operations for what we believe will become a burgeoning supply chain,” said Mark S. Chalmers, president and CEO of Energy Fuels. “There is a lot of excitement building for rare earths, because they make many clean energy and advanced technologies possible, including electric vehicles, wind generation, batteries and advanced electronics. Today’s announcement is a key milestone as our companies create, refine and grow a sustainable rare earth supply chain capable of supplying growing demand for clean technologies in the U.S. and Europe.”

To view the full press release, visit https://ibn.fm/DTfn8

About Energy Fuels Inc.

Energy Fuels is a leading U.S.-based uranium mining company, supplying U3O8 to major nuclear utilities. The company also produces vanadium from certain of its projects, as market conditions warrant, and anticipates commencing commercial production of rare earth element (“REE”) carbonate in 2021. Its corporate offices are in Lakewood, Colorado, near Denver, and all of its assets and employees are in the United States. Energy Fuels holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming, and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the U.S. today, has a licensed capacity of over 8 million pounds of U3O8 per year, has the ability to produce vanadium when market conditions warrant, as well as REE carbonate from various uranium-bearing ores. The Nichols Ranch ISR Project is on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is also on standby and has a licensed capacity of 1.5 million pounds of U3O8 per year. In addition to the above production facilities, Energy Fuels also has one of the largest NI 43-101 compliant uranium resource portfolios in the U.S. and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol “UUUU,” and the company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol “EFR.” For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

About MiningNewsWire

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is part of the InvestorBrandNetwork.

InvestorNewsBreaks – Splash Beverage Group Inc. (SBEV) Expands Distribution for ‘TapouT’ Performance Line

March 9, 2021 10:31:23

Splash Beverage Group (OTCQB: SBEV), a holding company of leading portfolio of beverage brands, today announced that it has secured Gulf Distributing of Florida and Gulf Distributing of Alabama for the company’s TapouT brand, a complete line of high-performance sports drinks containing a proprietary blend of essential vitamins, minerals and electrolytes. According to the update, the companies are divisions of Gulf Distributing Holdings L.L.C., which is one of the most established distributors in the Southeastern United States and operates seven individual beverage distributors that encompass central and southern Alabama, the panhandle of Florida and markets in Mississippi. “We have a 20-year relationship with Gulf Distribution and we are extremely excited to be working with their team again,” said Splash Beverage CEO Robert Nistico. “Our brand TapouT joins their blue-chip portfolio of Coors, Heineken, Corona, Red Bull, Essentia Water, 7-Up and Snapple, with statewide coverage in Alabama, including TapouT’s new authorization of 74 MapCo stores in the state.”

To view the full press release, visit https://ibn.fm/anvJk

About Splash Beverage Group Inc.

Splash Beverage Group specializes in manufacturing, distribution, sales and marketing of various beverages across multiple channels. SBEV operates in both the non-alcoholic and alcoholic beverage segments, which the company believes leverages efficiencies and dilutes risk. SBEV believes its business model is unique as it ONLY develops/accelerates brands it perceives to have highly visible pre-existing brand awareness or pure category innovation. For more information about the company, visit www.SplashBeverageGroup.com.

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

InvestorNewsBreaks – Friendable Inc.’s (FDBL) Fan Pass Sees February with 317 New Artists Sign Ups, Increasing Activity and Growth

March 9, 2021 10:08:27

Friendable (OTC: FDBL), a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications, has released an update for February noting rising activity and continued growth for its Fan Pass platforms. That growth includes the addition of 317 new artists and a 191% jump in live event streams and performances. Other metrics, including monthly platform impressions, fan/user sessions and social media followers, continued to grow as well. Friendable’s Fan Pass platform launched during COVID-19 as a solution for artists and their fans to remain connected and to continue to provide revenue opportunities for struggling artists. Friendable is confident that its virtual stage will continue to be a solution into the foreseeable future, protecting artist revenue streams should world or even local events limit earning potential. “It has been yet another month of confirming metrics for our team as we continue developing what we believe to be the most complete and really the best artist-centric live streaming platform available for music artists,” said Friendable CEO Robert A. Rositano Jr. in the press release. “Statistics are always invigorating to a team, especially as you continuously test new features, engage artists, fans or even potential sponsors, as we are doing. These efforts are allowing us to continue gaining the knowledge that, we believe, ultimately leads us to our next steps of progress and growth. Although advances are incremental and relatively small, this is by design. . . . We are here to stake our claim and market position, not to be here today and gone tomorrow. We are scaling at a pace that supports infrastructure growth that can keep pace at where we are today. I have no doubt we will continue picking up speed in all areas of our business as we keep putting one foot in front of the other, building this incredible platform.”

To view the full press release, visit https://ibn.fm/e9ehC

About Friendable Inc.

Friendable is a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications. Launched July 24, 2020, the company’s flagship offering is designed to help artists engage with their fans around the world and earn revenue while doing so. The livestreaming platform supports artists at all levels, providing exclusive artist content “channels,” live event streaming, promotional support, fan subscriptions and custom merchandise designs, all of which are revenue streams for each artist. With Fan Pass, artists can offer exclusive content channels to their fans, who can simply use their smartphones to gain access to their favorite artists as well as an all-access pass, giving them access to all artists on the platform. Additionally, the Fan Pass team will deploy social broadcasters to capture exclusive VIP experiences, interviews and behind-the-scenes content featuring their favorite artists — all available to fan subscribers for free on a trial basis. Thereafter, subscriptions are billed monthly at $3.99, or about the cost of downloading a couple of songs, providing VIP access at a fraction of the cost of traditional face-to-face meetups. Friendable Inc. was founded by Robert A. Rositano Jr. and Dean Rositano, two brothers with more than 27 years of experience working together on technology-related ventures. For more information about the company, visit www.Friendable.com.

NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

InvestorNewsBreaks – Mohawk Group Holdings Inc. (NASDAQ: MWK) Releases Q4, FY 2020 Financial Numbers, Business Update

March 9, 2021 09:17:42

Mohawk Group (NASDAQ: MWK), a technology-enabled consumer products company, reported its financial and business results for the fourth quarter and full year ended Dec. 31, 2020. Highlights of the report include a 61.9% increase in quarterly net revenue, totaling $41.5 million compared to $25.6 million in Q4 2019. Full-year net revenue saw a slightly higher increase, landing at $187.7 million, a 62.3% increase over 2019’s $114.5 million. Other numbers looked good, with full-year and fourth-quarter gross margins improving, fixed operating expenses decreasing, and full-year contribution margin reaching 13.5% over 2.2% in 2019. In business news, the company launched five new products in the last quarter, bringing the total launched products in FY 2020 to 37, compared to 32 the year before. In addition, the company announced a new CFO and appointed heads of corporate development in Europe and North America, with both positions focused on the company’s M&A pipeline. “I am proud of our team for delivering a strong Q4 and for our full-year results,” said Mohawk Group co-founder and CEO Yaniv Sarig in the press release. “Looking ahead in 2021, we expect to continue the momentum following our Healing Solutions acquisition as we continue to accelerate our accretive M&A strategy. We are currently evaluating a strong pipeline of potential M&A targets that in total have trailing twelve month’s net revenue of $522 million and trailing twelve month’s EBITDA of $97 million.” To view the full press release, visit https://ibn.fm/2m1DV About Mohawk Group Holdings, Inc. Mohawk Group is a rapidly growing technology-enabled consumer products company that uses machine learning, natural language processing and data analytics to design, develop, market and sell products. Mohawk predominantly operates through online retail channels such as Amazon and Walmart. Mohawk has twelve owned and operated brands and sells products in multiple categories, including home and kitchen appliances, kitchenware, environmental appliances (i.e., dehumidifiers and air conditioners), beauty-related products and, to a lesser extent, consumer electronics. Mohawk was founded on the premise that if a company selling consumer packaged goods was founded today, it would apply artificial intelligence and machine learning, the synthesis of massive quantities of data and the use of social proof to validate high-caliber product offerings as opposed to over-reliance on brand value and other traditional marketing tactics. For more information about this company, please visit www.MohawkGP.com. NOTE TO INVESTORS: The latest news and updates relating to MWK are available in the company’s newsroom at https://ibn.fm/MWK

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office www.InvestorWire.com [email protected]

InvestorWire is part of the InvestorBrandNetwork.

Creating Shareholder Value with a Machine-as-a-Service (MaaS) Business Model

March 9, 2021 09:05:41

NetworkNewsWire Editorial Coverage: The internet boom in the 1990s, with the genesis of application service providers (“ASP”), set the stage for the Software-as-a-Service (“SaaS”) model that now has found its way into nearly every industry. In a SaaS model, providers offer their technology over a set period of time, effectively locking in recurring revenue and a higher profit rather than selling the product outright. Since then, the “as-a-Service” model has been expanded into new verticals in a global economy now eager to accept the process. Because of large margins, Wall Street typically places high valuations on companies that employ the subscription “as-a-Service” model, especially when they have solved a problem and established strong market demand. Already disrupting the $500 billion security industry with its fully autonomous security robots, Knightscope Inc. (Profile) is establishing a new paradigm with its Machine-as-a-Service (“MaaS”) business model. The company already calls the federal government, public institutions and Fortune 1000 companies as clients as it employs a cost-effective subscription structure that is attractive to clients to augment traditional security systems and law enforcement functions. Others using similar business models that performed exceptionally well in 2020 include Axon Enterprise Inc. (NASDAQ: AXON), Intuitive Surgical Inc. (NASDAQ: ISRG), Peloton Interactive Inc. (NASDAQ: PTON) and Roku Inc. (NASDAQ: ROKU)…

About NetworkNewsWire

NetworkNewsWire (“NNW”) is a financial news and content distribution company, one of 40+ brands within the InvestorBrandNetwork (“IBN”), that provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

NetworkNewsWire is part of the InvestorBrandNetwork

DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by NNW are solely those of NNW. Readers of this Article and content agree that they cannot and will not seek to hold liable NNW for any investment decisions by their readers or subscribers. NNW is a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, NNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and NNW undertakes no obligation to update such statements.

420 with CNW — Legislators in Mexico to Vote on Cannabis Legalization Bill This Week

March 9, 2021 04:25:23

A vote to legalize cannabis in Mexico is scheduled for this week in the Chamber of Deputies; the vote comes months after the Senate approved the measure. Despite this move, however, legislators state that there’s still no formal revised legislation.

The Political Coordination Board, which was set up by party leaders to agree on various legislative matters, scheduled the proposed bill for floor action on March 9. Martha Tagle Martinez, a member of the chamber’s health committee, stated that there was still no draft opinion, adding that any legislation would have to pass through the Health and Justice Committee where it would be analyzed, discussed, and altered then that draft opinion…

NOTE TO INVESTORS: The latest news and updates relating to Grapefruit USA Inc. (OTCQB: GPFT) are available in the company’s newsroom at http://cnw.fm/GPFT

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Five Must-Know Things About CBD Shatter and Wax

March 8, 2021 16:25:22

Congress passed the Farm Bill in 2018, effectively legalizing the cultivation and sale of industrial hemp and its extracts after decades of prohibition. With farmers across the country taking part in pilot programs, a market for CBD quickly developed. The hemp extract is said to have a wide variety of health benefits, and preliminary reports coupled with anecdotal evidence have been encouraging.

Shatter and wax are without a doubt the most potent and quickest-acting means of consuming CBD. Shatter is an amber, translucent solid that is brittle to the touch while CBD wax looks just like wax and has a consistency similar to coconut oil. Both of them, collectively referred to as wax, are highly concentrated, with up to 80% CBD…

NOTE TO INVESTORS: The latest news and updates relating to The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) are available in the company’s newsroom at http://cnw.fm/WTER

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CNW420 is part of the InvestorBrandNetwork.

Investors Turning Their Backs on Mining Firms with Questionable Human Rights Records

March 8, 2021 15:13:05

Earlier this year, the Capital Markets Modernization Taskforce in the Ontario government gave a few recommendations for improving Ontario’s investment environment. In part, the body advocated for compulsory climate change-related disclosure and recognized that Environmental, Social and Governance standards played a huge role in the market and could impact a company’s financial performance. However, the body proposed a reporting standard that did not account for the social effects and risks of investing and failed to address Indigenous concerns and human rights.

Conversely, the internationally recognized UN Guiding Principles Reporting Framework requires that firms disclose any human rights…

NOTE TO INVESTORS: The latest news and updates relating to Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) are available in the company’s newsroom at https://ibn.fm/EXN

About MiningNewsWire

MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is part of the InvestorBrandNetwork.

BioMedNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) to Present at Inaugural Emerging Growth Virtual Conference

March 8, 2021 14:41:13

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that it will present at the Inaugural Emerging Growth Virtual Conference, hosted by M Vest LLC and Maxim Group LLC. The conference is slated to take place from 9:00 a.m.-5:00 p.m. ET on March 17 – 19, 2021, and will feature roundtable discussions with C-suite executives moderated by Maxim Research analysts, fireside chats with live Q&A, as well as presentations from hundreds of domestic and international issuers. According to the update, 180 Life Sciences’ CEO Dr. James Woody will be available for one-on-one meetings, which investors may request through Maxim Group.

To view the full press release, visit https://ibn.fm/ypbEG

About 180 Life Sciences Corp.

180 Life Sciences is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. 180 Life Sciences is leading the research into solving one of the world’s biggest drivers of disease – inflammation. The company is driving groundbreaking study into clinical programs, which are seeking to develop novel drugs addressing separate areas of inflammation for which there are no effective therapies. The company’s primary platform is a novel program to treat fibrosis using anti-TNF (tumor necrosis factor), with its lead program in phase 2b/3 clinical trials. For more information, visit the company’s website at www.180LifeSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to ATNF are available in the company’s newsroom at http://ibn.fm/ATNF

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork

BioMedNewsBreaks – GT Biopharma Inc. (NASDAQ: GTBP) Releases Preclinical Results for Prostate Cancer Treatment

March 8, 2021 13:56:45

GT Biopharma (NASDAQ: GTBP), a clinical-stage biopharmaceutical company focused on disruptive, target-directed natural killer (“NK”) cell engager immunotherapy technologies, has announced preclinical results for its ROR1 (“ROR1”) TriKE(TM) (“TriKE”) product candidate, which is being evaluated as a prospective therapy for the treatment of prostate cancer. The treatment is based on the fact that tyrosine kinase transmembrane receptor ROR1 has been shown to be overexpressed on certain cancer cells and to play a functional role in influencing the metastatic potential of various solid tumor cancers. Through its TriKE treatment, GT Biopharma targets ROR1 on cancer cells, redirecting NK cells to attack and kill cancer cells that express ROR1. The hope is that the therapeutic treatment will limit the metastatic potential and invasiveness of certain solid tumor cancers. In previous preclinical models of prostate cancer, ROR1 TriKE was found to be effective at promoting NK cell killing of multiple prostate cancer cells. “We are pleased to report our ROR1 TriKE has passed this important preclinical milestone, and demonstrated effectiveness in promoting redirected and target-specific killing by NK cells,” said GT Biopharma chairman and CEO Anthony J. Cataldo in the press release. “We plan to evaluate the ROR1 TriKE in additional IND-enabling preclinical studies with the goal of transitioning to a phase I/II clinical trial.”

To view the full press release, visit https://ibn.fm/dnLgT

About GT Biopharma Inc.

GT Biopharma is a clinical-stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based on the company’s proprietary TriKE(TM) (“TriKE”) natural killer (“NK”) cell engager platform. The TriKE platform is designed to activate and redirect the target cell killing abilities of the patient’s NK cells without the need for supplemental ex vivo engineered donor or autologous NK cells, or induced pluripotent stem cells (“iPSC”). GT BioPharma has an exclusive worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE technology. GT Biopharma’s lead TriKE product candidate, GTB-3550 TriKE, is being evaluated in a multicenter phase I/II trial for the treatment of acute myeloid leukemia, myelodysplastic syndrome and other CD33+ hematopoietic malignancies. For more information about the company, please visit www.GTBioPharma.com.

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork

BioMedNewsBreaks – MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) Develops First-Ever Effective Treatment for Root-Rot Disease

March 8, 2021 13:49:00

MustGrow (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) has announced that its plant-based biopesticide is 100% effective against root-rot disease. This announcement followed a recent round of laboratory tests, “which were conducted by an independent third-party lab,” an article on MustGrow’s novel accomplishment details. MustGrow, an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops such as fruits and vegetables, becomes the first to develop an effective treatment for this disease. The “patented mustard-derived biopesticide achieved 100% control over Aphanomyces euteiches zoospores (Aphanomyces) within 24 hours and at economic application rates… Aphanomyces is a soil-borne, root-rot disease that destroys peas, lentils and legume crops, commonly referred to as pulse crops. In infected fields, the disease can result in yield losses ranging from 10% to 100% complete destruction… Currently the only available treatments slow down the spread in an attempt to reduce the severity of the disease; no treatments exist that control the devastating root-rot plague. MustGrow’s plant-based biopesticide aims to change that.”

To view the full article, visit https://ibn.fm/irMWy

About MustGrow Biologics Corp

MustGrow is a publicly traded agriculture biotech company focused on providing natural science-based biological solutions for high-value crops, including fruits and vegetables. MustGrow has designed and owns a United States EPA-approved natural solution that uses the mustard seed’s natural defense mechanism to protect plants from pests and diseases. Over 110 independent tests have been completed, validating MustGrow’s safe and effective signature products. The product, in granule format, is EPA-approved across all key U.S. states and by Health Canada’s PMRA (Pest Management Regulatory Agency) as a bio-pesticide for high-value crops such as fruit and vegetables. MustGrow has now concentrated a liquid format, TerraMG, which, with regulatory approval, could be applied through standard drip or spray equipment, improving functionality and performance features. For more information, visit the company’s website at www.MustGrow.ca.

NOTE TO INVESTORS: The latest news and updates relating to MGROF are available in the company’s newsroom at https://ibn.fm/MGROF

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork

InvestorNewsBreaks – Why Mohawk Group Holdings Inc. (NASDAQ: MWK) Is ‘One to Watch’

March 8, 2021 13:34:12

Mohawk Group Holdings (NASDAQ: MWK) is a leading tech-enabled consumer products platform that utilizes machine learning, natural language processing and data analytics to design, develop, market, and sell products. Mohawk’s proprietary AIMEE(R) platform leverages data and artificial intelligence (“AI”) to automate the design, development and launch of best-selling consumer products. The company owns and operates 12 brands to sell consumer products across multiple categories ranging from kitchenware and home appliances to environmental appliances, beauty offerings and even consumer electronics. A recent article discussing the company reads, “AIMEE(R) (AI Mohawk E-commerce Engine) is Mohawk’s proprietary platform that leverages data and AI to: identify new market opportunities; launch new products; automate marketing variables; and analyze and optimize company-owned and operated consumer product brands.”

To view the full article, visit https://ibn.fm/ZGQg4

About Mohawk Group Holdings Inc.

Mohawk Group Holdings, together with its subsidiaries (“Mohawk”), is a rapidly growing technology-enabled consumer products company that uses machine learning, natural language processing and data analytics to design, develop, market and sell products. Mohawk predominantly operates through online retail channels such as Amazon and Walmart. Mohawk has 12 owned and operated brands and sells products in multiple categories, including home and kitchen appliances, kitchenware, environmental appliances (i.e., dehumidifiers and air conditioners), beauty-related products and, to a lesser extent, consumer electronics. Mohawk was founded on the premise that if a company selling consumer packaged goods was founded today, it would apply artificial intelligence and machine learning, the synthesis of massive quantities of data and the use of social proof to validate high-caliber product offerings as opposed to over-reliance on brand value and other traditional marketing tactics. For more information, visit the company’s website at www.MohawkGp.com.

NOTE TO INVESTORS: The latest news and updates relating to MWK are available in the company’s newsroom at https://ibn.fm/MWK

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

BioMedNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Opens First-Ever Pneusomnia Clinic, Unveils New Tech to Test for Sleep Apnea at Home

March 8, 2021 13:27:35

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing including obstructive sleep apnea (“OSA”), has opened the first Pneusomnia clinic, a clinician-owned, integrated medical-dental sleep center. The center will feature the Vivos System through its Medical Integration Division. Located in Del Mar, California, the clinic is owned and operated by local physicians, including Dr. Mimi Guarneri, a cardiologist, founder and president of the Academy of Integrative Health and Medicine; she will lead the center. Vivos created its Medical Integration Division last year with the objective of fostering an environment where medical doctors and dentists could work together in treating sleep disorders. The new sleep medicine center will offer the Vivos System, a clinically effective, nonsurgical, noninvasive, nonpharmaceutical oral appliance treatment for mild-to-moderate sleep apnea. In addition to the opening of the new center, Vivos recently launched a new testing technology called VivoScore(TM), powered by SleepImage(R). According to the announcement, VivoScore is a home sleep apnea test (“HSAT”) that builds upon proprietary cardiopulmonary coupling technology developed by SleepImage, or MyCardio LLC, which has been FDA cleared for the purpose of diagnosing OSA. The device includes a single-sensor ring recorder that connects with a smartphone app and uses proprietary cloud-based algorithms to evaluate sleep quality and clinically diagnose sleep apnea in a person’s own home. Studies indicate that VivoScore test results are comparable to overnight in-lab polysomnogram (“PSG”) tests. VivoScore can be used for both children and adults, and is designed to increase access and decrease costs of other HSAT options. “With the medical and dental communities coming together through the Pneusomnia clinics to both diagnose and treat OSA, patients will have access to the Vivos System, our leading-edge technology that helps to alter the size, shape and position of their upper airway tissues,” said Vivos CEO Kirk Huntsman in one of the press releases. “We look forward to continuing our work with Dr. Guarneri to bring as many patients into the new facility as possible. With additional centers opening later this year across the country, and over 1,200 independent dentists in the U.S. and Canada who are now using the Vivos System, we believe we are poised to reach even more undiagnosed patients than ever before.”

To view the full press releases, visit https://ibn.fm/NPDYU and https://ibn.fm/y51cb

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing including obstructive sleep apnea (“OSA”). The Vivos treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. Vivos believes that its Vivos System technology represents the first clinically effective, nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Vivos oral appliances have proven effective in more than 18,000 patients treated worldwide by more than 1,200 trained dentists. Combining technologies and protocols that alter the size, shape and position of the tissues of a patient’s upper airway, the Vivos System opens airway space and can eliminate or significantly reduce symptoms and conditions associated with mild-to-moderate OSA. The Vivos System has been shown to significantly lower Apnea Hypopnea Index scores and improve other conditions associated with OSA. The Vivos Integrated Practice (“VIP”) program offers dentists training and other value-added services in connection with using the Vivos System. For more information about this company, visit www.VivosLife.com.

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork

ROTH Announces Health & Wellness Track for Virtual 33rd Annual Roth Conference

March 8, 2021 13:07:12

ROTH is hosting its 33rd Annual Roth Conference virtually this year, from March 15-17. A key part of the conference is scheduling 1-on-1/small group meetings for institutional investors to meet with leading Health and Wellness companies, including U.S. cannabis operators, global operators, ancillary providers, and hemp CBD companies. In addition, ROTH is hosting virtual fireside chats and three industry panels discussing the burgeoning industries of cannabis and psychedelics.

COMPANIES AVAILABLE FOR 1X1 MEETINGS…

For more information on this year’s event, visit https://ibn.fm/8FZRB

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

InvestorNewsBreaks – Asia Broadband Inc. (AABB) Engages InvestorBrandNetwork for Corporate Communications Expertise

March 8, 2021 12:57:08

Asia Broadband (OTC: AABB), a resource company focused on the production, supply and sale of precious and base metals, today announced that it has selected the corporate communications expertise of the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. Asia Broadband leverages a vertically integrated approach to sales transactions, utilizing its specific geographic expertise, experience and extensive industry contacts to facilitate its innovative distribution process from the production and supply of precious and base metals in Mexico to client networks in Asia. As part of the Asia Broadband and IBN relationship, IBN will leverage its investor based distribution network of 5,000+ key syndication outlets, various newsletters, social media channels, wire services via InvestorWire, blogs and other outreach tools to generate greater awareness for Asia Broadband. “We are pleased to engage IBN to maximize our communication with existing and potential shareholders while refining our overall messaging and outreach,” said James Gilbert, CEO of Asia Broadband.

To view the full press release, visit https://ibn.fm/arCdj

About Asia Broadband Inc.

NOTE TO INVESTORS: The latest news and updates relating to AABB are available in the company’s newsroom at https://ibn.fm/AABB

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Cross-Border Mining Sector Deals Total $2.4B in Last Quarter of 2020 in North America

March 8, 2021 12:51:15

During the last quarter of 2020, the mining and metals industry in North America registered a 6.98% decline in cross-border deal activity. This is according to the most recent data from analysis conducted by GlobalData, which compared numbers from 2020’s last quarter to the average of the last four quarters.

While the average of the last four quarters had 43 cross-border deals, 2020’s final quarter announced 40 cross-border deals in the region, which…

NOTE TO INVESTORS: The latest news and updates relating to Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) are available in the company’s newsroom at http://ibn.fm/UUUU

About MiningNewsWire

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is part of the InvestorBrandNetwork.

InvestorNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Showcases Virtual Event Platform Capabilities at Prestigious B. Riley Vision Day

March 8, 2021 12:46:36

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, recently served as the exclusive technology host for B. Riley Securities’ 2021 Vision Day. The prestigious event was held on the Sequire Virtual Events platform, which allowed the Sequire community privileged access to sessions and content. The daylong virtual investor conference featured video presentations and fireside chats discussing top stock picks from B. Riley’s award-winning equity research team. “We were honored to have been selected by B. Riley Securities to host its 2021 Vision Day event following our success with the LD Micro Main Event in December,” said SRAX founder and CEO Christopher Miglino in a recent update. “This event is a perfect example of our growing Virtual Event Platform capabilities. We were pleased to work with the B. Riley team and contribute to another successful event.” To view the full article, visit https://ibn.fm/5uvGH About SRAX Inc. SRAX is a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform, Sequire, companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information about the company, visit www.SRAX.com and MySequire.com. NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office www.InvestorWire.com [email protected]

InvestorWire is part of the InvestorBrandNetwork.

BioMedNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Development of Newly Designed System for Direct-to-Drain Fluid Waste Management

March 8, 2021 12:26:39

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that its Skyline Medical Division is renewing the development of a new Generation 3 STREAMWAY(R) System for direct-to-drain fluid waste management. According to the update the new device will see no change to its intended use and will not require a separate 501(k) submission with the Food and Drug Administration. In addition, the new design will include key changes to the product that will be smaller, lighter and easier to install with the goal of improving operator reliability, reducing manufacturing costs, increasing durability and simplifying servicing. “Skyline Medical plans to follow shortly with a Generation 3 Plus machine, which includes an integrated on-board vacuum pump so the facility vacuum supply will not be required or at the least can be augmented if needed,” said Dr. Carl Schwartz, CEO of Predictive Oncology.

To view the full press release, visit https://ibn.fm/Khin8

About Predictive Oncology Inc.

Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. TumorGenesis Inc. specializes in media that help cancer cells grow and retain their DNA/RNA and proteomic signatures, providing researchers with a tool to expand and study cancer cell types found in tumors of the blood and organ systems of all mammals, including humans. Skyline Medical markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. Soluble Biotech is a provider of soluble and stable formulations for proteins including vaccines, antibodies, large and small proteins, and protein complexes. For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork

Low-Cost Chinese EV Muscling Tesla Inc. (NASDAQ: TSLA) Out of Sales

March 8, 2021 12:15:03

Tesla (NASDAQ: TSLA) is facing stiff competition in China, its largest market for electric vehicles (“EVs”) after North America. The EV company has been the leading electric vehicle company globally for a while now, selling thousands of battery electric vehicles (“BEV”) across the United States, Europe, and China. However, the nascent EV industry has attracted plenty of companies that are giving Tesla a run for its money, especially in China, the world’s largest electric vehicle market.

The Hong Guang Mini EV, a compact $4,500 EV developed by SAIC Motor, has proven a big hit in China. Last month, the budget EV saw sales that were close to double what Tesla sold in the same period in China. It is being developed in the country as part of a joint measure between SAIC Motor, a state-owned company that holds the distinction of being the top automaker in China, Liuzhou Wuling Motors, and American automaker…

NOTE TO INVESTORS: The latest news and updates relating to ev Transportation Services Inc. are available in the company’s newsroom at https://ibn.fm/EVTS

About Green Car Stocks

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
[email protected]

Green Car Stocks is part of the InvestorBrandNetwork.

Relax, Robots Have it Handled

March 8, 2021 12:07:39

Massive opportunity ahead says CEO of Autonomous Security Robot maker Knightscope
Wide ranging interview discloses vast potential in federal applications
Knightscope’s state of the art ASRs provide cost effective 24/7/365 security

The rise of machines has arrived. Relax, it isn’t the rise of Skynet, the malevolent neural network superintelligence system from the movie Terminator. This rise of machines has no malice. In fact, these machines benefit society by uniquely combining robotics, self-driving technology, and artificial intelligence to reduce crime as well as provide safety, security, and real-time data in a multitude of settings.

With the rise of its Autonomous Security Robots (“ASRs”), tech innovator Knightscope is on track to revolutionize the $500 billion security industry. The company is rapidly displacing moribund security duties across the country and its ASRs are already on-guard in federal government facilities, public institutions, and…

NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/Knight

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Ideanomics Inc. (NASDAQ: IDEX) Acquires 20% Stake in Italian Listed Electric Motorcycle Maker Energica

March 8, 2021 11:58:03

Ideanomics, Inc. (NASDAQ: IDEX) recently entered into an investment agreement promising to purchase over 6 million Energica ordinary shares using a subscribed-shares arrangement that priced each subscribed share at Euro 1.78
In total, IDEX would invest approximately 13 million dollars in the Italy-based manufacturer of all-electric high-performance motorcycles
According to IDEX CEO Alf Poor, the investment was driven by Energica’s manufacture of high-performance products that produce zero emissions
In 2020, Energica experienced a 187% increase in revenue compared to 2019, and there is high demand for Energica’s motorcycles in the U.S.

Ideanomics (NASDAQ: IDEX), a global company focused on investing in and promoting innovative solutions in the financial and electric vehicle (“E.V.”) spaces, recently entered into an investment agreement with Energica Motor Company S.p.A. (“Energica”), an Italian listed electric motorcycle company, that will see it acquire at least 20% of Energica, upon completion of the requisite transactions.

According to a March 4 announcement issued by Energica, IDEX promised to purchase 64% of the share capital increase, the equivalent of 6,128,703 Energica ordinary shares, in a subscribed-shares arrangement. Notably, subscribed shares are shares that investors promise to buy as part of…

NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

InvestorNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) Reports Continued Month-over-Month Growth

March 8, 2021 11:51:37

PowerBand Solutions’ (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA), a comprehensive e-commerce solution allowing drivers and automotive dealers to buy, sell, trade, lease and finance vehicles from any digital device, has released its February 2021 financial numbers, noting that the company’s strong month-over-month growth has continued into 2021. In the announcement, PowerBand reported that its February’s gross salestotaled C$8 million, which is a 19.4% or C$1.3 million increase over its January 2021 numbers of C$6.7 million. This is particularly noteworthy because February is a short month, which included a major cold-weather incident that negatively impacted the economy in much of the country, including Texas, a key PowerBand market. PowerBand reports that year-to-date gross sales for 2021 are C$14.7 million, which is edging closer to PowerBand’s 2020 year-to-date gross sales of C$21.7 million. “We are continuing to grow our market share and move toward profitability because the DRIVRZ(TM)virtual marketplace is eliminating the need for drivers and dealers to engage unnecessary middlemen when they buy, sell, lease, trade, finance and insure vehicles,” said PowerBand CEO Kelly Jennings in the press release. “TheDRIVRZvirtual marketplace is truly disruptive because we do not acquire and hold costly inventory. Instead, we offer access to more than 4.5 million vehicles through our data bases and facilitate the ability of drivers and dealers to connect to those vehicles. We do not pass on substantial inventory-holding costs to the user and eliminate the bottom-line risk to the company of debt costs and depreciating inventory.” To view the full press release, visit https://ibn.fm/Dje0P About PowerBand Solutions Inc. PowerBand Solutions, listed on the TSX Venture Exchange and the OTCQB markets, is a fintech provider disrupting the automotive industry. PowerBand’s integrated, cloud-based transaction platform facilitates transactions among consumers, dealers, funders and manufacturers (“OEMs”). The platform enables users to buy, sell, trade, finance, and lease new and used, electric- and non-electric vehicles, on smartphones or any other online digital devices, from any location. PowerBand’s transaction platform — being trademarked under DRIVRZ — will be available across North American and global markets. For more information, please visit www.PowerBandSolutions.com. NOTE TO INVESTORS: The latest news and updates relating to PWWBF are available in the company’s newsroom at http://ibn.fm/PWWBF

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office www.InvestorWire.com [email protected]

InvestorWire is part of the InvestorBrandNetwork.

USF, Partners Obtain DEA Authorization to Study Psychedelics for CNS Disorders

March 8, 2021 11:44:48

In partnership with the University of South Florida (“USF”) and its chemical screening and purification facility, Psilera Bioscience has acquired approval from the DEA to study psilocin, which is an active psychedelic component found in psilocybin mushrooms and ayahuasca tea, psilocybin and DMT (N,N-dimethyltryptamine).

USF and Psilera join other universities across the United States that are also conducting psychedelic research on various psychedelic compounds. Psilera’s objective is to be the pioneer…

NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) (OTC: CLXPF) are available in the company’s newsroom at https://ibn.fm/CYBN

About PsychedelicNewsWire

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]

PsychedelicNewsWire is part of the InvestorBrandNetwork.

GreenCarNewsBreaks – Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) Appoints Former Shell Oil Exec to PowerTap Board

March 8, 2021 11:42:19

Clean Power Capital (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF), an investment company, announced that it has appointed David Bray, a former general manager and corporate officer for Shell Oil Products US, to the advisory board of PowerTap Hydrogen Fueling Company, an investee company. In his new role, Bray will provide insight and expertise in critical product development and services related to accelerating the development of PowerTap’s proprietary modular 1,250 kg hydrogen production and dispensing unit. Bray has more than three decades of experience in the business and strategy development and fuels and marketing sectors. While at Shell, he served as general manager over several different groups, and his work focused heavily on downstream, customer-facing businesses, as well as the future of energy. In addition to his appointment as board member, Bray and his company, Bray Retail Consulting LLC will join PowerTap for one year in a consulting role. Bray, who believes that hydrogen will play a critical role in meeting the energy needs of the Americas in the future, will assist PowerTap as the company works to bring its IP to the market. “We are thrilled to appoint David Bray to PowerTap’s advisory board,” said PowerTap CEO Raghu Kilambi in the press release. “He has a thorough and complete understanding of this industry and has a proven track record of delivery. We are excited to have him join our Advisory Board and as an exclusive consultant as we look to commercialize our PowerTap onsite hydrogen generation with the Andretti Group across the USA.”

To view the full press release, visit https://ibn.fm/X4Rjl

About Clean Power Capital Corp.

Clean Power is an investment company that specializes in investing in private and public companies opportunistically that may be engaged in a variety of industries, with a current focus in the health and renewable energy industries. In particular, Clean Power’s investment mandate is focused on high-return investment opportunities, the ability to achieve a reasonable rate of capital appreciation and seeking liquidity in its investments. For more information about the company, please visit www.CleanPower.Capital.

NOTE TO INVESTORS: The latest news and updates relating to MOTNF are available in the company’s newsroom at https://ibn.fm/MOTNF

About Green Car Stocks

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
[email protected]

Green Car Stocks is part of the InvestorBrandNetwork.

BioMedNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Plans to Participate in 33rd Annual ROTH Conference, $10M Registered Direct Offering

March 8, 2021 11:18:51

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases, today announced that its CEO and Chairman, James Sapirstein, will participate in a panel discussion during the ROTH Conference slated to be held virtually from March 15-17, 2021. According to the update, the panel, “Therapeutics Against SARS-CoV-2 – Viral Variants Will Not Fade Away: A discussion of various developmental therapeutics for SARS-CoV-2 infection,” is scheduled to begin at 12:00 p.m. ET on March 15, 2021. During the panel, Sapirstein will discuss the need for drug therapies to address issues related to COVID-19, including the prevalence of gastrointestinal symptoms in an increasing number of people infected by the virus.

In addition, AzurRx BioPharma announced its entry into a definitive agreement with a single healthcare-focused institutional investor for the issuance and sale of an aggregate of 7,858,548 shares of common stock (or common stock equivalent) and warrants to purchase up to an aggregate of 3,929,274 shares of common stock at an effective purchase price of $1.2725 per share and accompanying warrant in a registered direct offering priced at-the-market under Nasdaq rules. The warrants are exercisable immediately, at an exercise price of $1.21 per share, and will expire five years following the date of issuance. Subject to the satisfaction of customary conditions, the closing of the offering is expected to occur on or about March 10, 2021. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

To view the full press releases, visit https://ibn.fm/3RWa3 and https://ibn.fm/tc8Y0

About AzurRx BioPharma Inc.

AzurRx BioPharma is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases. The company has a pipeline of three gut-restricted GI assets. The lead therapeutic candidate is MS1819, a recombinant lipase for the treatment of exocrine pancreatic insufficiency (“EPI”) in patients with cystic fibrosis and chronic pancreatitis, currently in two Phase 2 clinical trials. AzurRx is launching two clinical programs in 2021 using proprietary formulations of niclosamide, a pro-inflammatory pathway inhibitor, FW-420, for grade 1 immune checkpoint inhibitor colitis and diarrhea in oncology patients and FW-1022, for COVID-19 gastrointestinal infections. The company is headquartered in Delray Beach, Florida with clinical operations in Hayward, California. For more information, visit www.AzurRx.com.

NOTE TO INVESTORS: The latest news and updates relating to AZRX are available in the company’s newsroom at https://ibn.fm/AZRX

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork

Scientists Work to Develop Everyday Objects with Germ-Killing Capabilities

March 8, 2021 11:13:51

Researchers are working on advances in the fields of nanotechnology and biomaterials which may help develop objects that eliminate viruses automatically.

Breakthroughs in the advancements made in both fields could help fight against deadly viruses like the SARS-CoV-2 virus, which is the strain…

NOTE TO INVESTORS: The latest news and updates relating to CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are available in the company’s newsroom at https://ibn.fm/CNSP

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork.

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Takes Bladder Cancer Battle to Next Level

March 8, 2021 10:52:27

Imagin Medical has developed a technology, currently entering the manufacturing stage, which it believes will revolutionize bladder cancer surgical imaging
The company’s technology, the i/Blue Imaging System, can display blue and white light images of the bladder side-by-side simultaneously, allowing surgeons greater ability to detect and remove tumors
Imagin has raised a $2.165 million convertible note offering to fund the company during the manufacturing phase of its surgical imaging system as well as the U.S. Food and Drug Administration (“FDA”) approval process
Bladder cancer is one of the most prevalent cancers in the United States, particularly in men, and is expected to result in the deaths of roughly 17,200 patients this year — approximately 71 percent of them men

The American Cancer Society forecasts that in 2021 about 83,730 new cases of bladder cancer will be diagnosed in the United States, about 77 percent of them in men. And that about 17,200 bladder cancer cases will result in death, about 71 percent of them in men (https://ibn.fm/6NEqE). While bladder cancer rates have been declining for the past decade, the ACS predicts there will be a 3 percent increase this year (https://ibn.fm/8KYwX).

Imagin Medical (CSE: IME) (OTCQB: IMEXF) is preparing to commercialize its proprietary i/Blue Imaging(TM) System once final U.S. Food and Drug Administration (“FDA”) approval has been granted. The purpose-built mission of the i/Blue Imaging System is to bring about a…

NOTE TO INVESTORS: The latest news and updates relating to IMEXF are available in the company’s newsroom at https://ibn.fm/IMEXF

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork.

PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Commences Trading on the OTCQB(R) Venture Market

March 8, 2021 10:41:58

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, today announced that its shares have commenced trading on the OTCQB(R) Venture Market under the symbol “CLXPF.” “With the commencement of trading on the OTCQB, Cybin has achieved another important milestone on its path to advancing mental health care through evidenced-based therapeutics. This additional capital markets exposure offers us greater visibility within the investment community, which should enhance our liquidity and increase our access to institutional and retail investors,” said Doug Drysdale, CEO of Cybin. “This support is extremely valuable to us as we continue to progress our psychedelic drug development programs that target mental health disorders, such as major depressive disorder, and other therapy-resistant psychiatric disorders.”

To view the full press release, visit https://ibn.fm/RRiBb

About Cybin Inc.

Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. For more information, visit the company’s website at www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About PsychedelicNewsWire

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]

PsychedelicNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) Announces Update on Informal Acquisition Inquiry

March 8, 2021 10:32:51

Grapefruit USA (OTCQB: GPFT), a premiere, fully licensed California-based cannabis company, today released a further update on its recent announcement that it has been approached by a Canadian cannabis company (the “Canadian Partner”) to enter into discussions concerning a potential acquisition transaction and joint venture to manufacture, distribute and market Grapefruit’s products, specifically Grapefruit’s patented Hourglass(TM) THC/Cannabinoid time-release delivery cream throughout Canada. “We were recently informed by the Canadian Partner that it has duly noticed a shareholder’s meeting for early April 2021, at which it will, among other matters, consider and potentially seek approval of the potential joint venture and/or acquisition and intends immediately thereafter to seek finalization of the terms of the joint venture and further detailed discussions on a related acquisition,” said Grapefruit CEO Bradley J. Yourist. “Grapefruit is pleased that the Canadian Partner has chosen this course of action as it provided us with objective evidence of their bona fides. As we stated before, the joint venture may precede without precluding an acquisition as we continue to take steps to ascertain and evaluate the capital requirements and various legal, regulatory and logistical challenges of finalizing a joint venture and/or the related acquisition. Once again, that being said, we wish to emphasize that the discussions reported here, although largely positive, remain preliminary in nature and may be terminated at any time. Grapefruit will update the public as necessary on any material joint venture or acquisition developments as events proceed.”

To view the full press release, visit https://cnw.fm/FTTRO

About Grapefruit USA Inc.

Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products in the Golden State. Grapefruit’s extraction laboratory and manufacturing and distribution facilities are located in the industry-recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, located on the extension of North Canyon Road, approximately 14 miles north of downtown Palm Springs. For more information about the company, visit www.GrapefruitBlvd.com.

NOTE TO INVESTORS: The latest news and updates relating to GPFT are available in the company’s newsroom at https://cnw.fm/GPFT

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is part of the InvestorBrandNetwork.

InvestorNewsBreaks – TAAT(TM) Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Announces Initial Rollout of TAAT Via CROSSMARK

March 8, 2021 10:14:39

TAAT(TM) Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) has announced that initial steps to roll out its TAAT(TM) product has begun through its previous agreement with CROSSMARK, a Texas-based consumer packaged goods (“CPG”) sales agency. The rollout began in Ohio with the objective of strengthening TAAT’s existing presence in the state. CROSSMARK reports that more than three-quarters of its Ohio retail accounts that have been approached have indicated an interest in carrying the TAAT product; CROSSMARK will be providing service to more than 7,000 convenience stores in Ohio in Q2 2021. The retail rollout kicked off about the same time TAAT launched its online presence, which offers the company’s flagship products, TAAT Original, Smooth andMentholto adult-aged smokers located in certain areas of the country. “These are exciting times for the company as we enter the final month of Q1 2021,” said TAAT CEO Setti Coscarella in the press release. “Now that our product line has had the opportunity to be tested by smokers aged 21+ across Ohio with consistently positive reception, we can start to roll TAAT out more aggressively with the knowledge that we have a solid product formulation and commercialization playbook. . . . We are excited to see the impact CROSSMARK will have on the overall performance of TAAT as we continue our push to capture additional market share in the USD $814 billion global tobacco industry.”

To view the full press release, visit https://ibn.fm/r37eZ

About TAAT Lifestyle & Wellness Ltd.

TAAT Lifestyle and Wellness has developed TAAT, which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in Original, Smooth and Menthol varieties. TAAT’s base material is Beyond Tobacco(TM), a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with Big Tobacco pedigree, TAAT was launched first in the United States in Q4 2020 as the company seeks to position itself in the $814 billion global tobacco industry. For more information, please visit www.TAATGlobal.com.

NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

GreenCarNewsBreaks – Net Element Inc. (NASDAQ: NETE), Mullen Technologies Enter Strategic Partnership with NexTech Batteries

March 8, 2021 10:04:22

Net Element (NASDAQ: NETE) is in the process of transforming its business model to become a pure-play electric vehicle (“EV”) manufacturer through a pending merger with privately-held Mullen Technologies Inc. Mullen has announced entry into a strategic partnership with NexTech Batteries Inc. as an EV battery supplier and key partner for battery development and technologies. Under the collaboration, Mullen plans to produce more than 100,000 vehicles over five years using NexTech lithium sulfur (“Li-S”) pouch format batteries, which are 60% lighter than today’s EVs, improving vehicle efficiency and reducing overall energy consumption. NexTech’s sulphur is sourced from oil refinement by-products, which are fully recyclable, sustainable, ubiquitously available and inexpensive. In addition, Mullen is committed to reducing greenhouse gas emissions in every aspect of its business, including the use of low carbon footprint materials and emerging technologies, in this case, readily available sulphur. “This technology allows Mullen to potentially be below $90/kWh at a pack level, greatly reducing cost to consumers,” said Frank McMahon, Mullen CTO. “The low carbon footprint, high specific energy density and much lower cost to the consumer will make Mullen extremely competitive in this market segment.”

To view the full news release, visit https://ibn.fm/f7tye

About Net Element Inc.

Net Element operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the U.S. and selected emerging markets. On Aug. 5, 2020, Net Element announced the execution of a definitive agreement to merge with privately-held Mullen Technologies Inc., a Southern California-based electric vehicle company in a stock-for-stock reverse merger in which Mullen’s stockholders will receive a majority of the outstanding stock in the post-merger company (the “contemplated merger”). That contemplated merger is subject to customary closing conditions, regulatory approvals and shareholder approval for both companies. For additional information, visit www.NetElement.com.

NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://ibn.fm/NETE

About Green Car Stocks

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
[email protected]

Green Car Stocks is part of the InvestorBrandNetwork.

InvestorNewsBreaks – Knightscope Inc. Adds Another Customer to Growing List of ASR Users

March 8, 2021 10:04:00

Knightscope, an advanced security technology company that builds fully autonomous security robots that deter, detect and report, announced that it has inked a deal with a downtown Phoenix commercial high-rise client to deploy its proprietary autonomous security robot (“ASR”). In an article titled “Knightscope Is Flourishing in the Deseret Sun,” the company noted that it is thrilled to see property owners and managers continue to integrate advanced security technologies to create safe environments for their tenants and visitors. “As a region, we’re on a relentless pursuit of innovation and technology,” stated the Greater Phoenix Economic Council in the article. “Companies here are committed to changing the game, and the region’s ecosystem enables success. To us, connectivity is about our region’s legacy businesses joining forces with emerging disruptors.”

To view the full article, visit https://ibn.fm/DpOPG

About Knightscope Inc.

Knightscope is an advanced security technology company based in Silicon Valley that builds fully autonomous security robots that deter, detect and report. The company’s long-term ambition is to make the United States of America the safest country in the world. For more information about the company, please visit www.Knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/Knight

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

InvestorNewsBreaks – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) Completes First Tranche of Private Placement for More than $2M

March 8, 2021 09:31:22

GoldHaven Resources (CSE: GOH) (OTCQB: GHVNF), a Canada-based company engaged in the business of acquiring and exploring mineral resource properties, announced that it had closed the first tranche of its previously announced nonbrokered private placement. The private placement was to consist of no more than 6 million units, which were sold at $0.50 per unit. GoldHaven closed on the placement on March 5, 2021; the company issued 4,677,800 units, which were sold at the aforementioned $0.50 price per unit, resulting in gross proceeds of $2,338,900 for the company. According to the announcement, each unit comprised one common share of the company and one-half of one common share purchase warrant. The purchase warrant entitles the holder to purchase an additional common share of the company at $0.65 per share for 36 months after the closing of the offering. GoldHaven noted in the announcement that it intends to use the net proceeds from the offering for drilling on its Maricunga Gold Belt projects as well as general working capital. To view the full press release, visit https://ibn.fm/vxhap About GoldHaven Resources Corp. GoldHaven Resources is a Canadian junior exploration company active in the Maricunga Gold Belt of Northern Chile. The Maricunga Belt measures 150 km. north-south and 30 km east-west and is host to numerous discoveries over the past 20 years; the area has a prolific gold, silver and copper metal endowment. GoldHaven has agreements in place to acquire seven high-priority exploration targets, which were identified by geological studies. To date, GoldHaven considers four of these seven properties high-priority targets and will commence drilling during the first quarter of 2021. The four priority targets include Coya, located approximately 16 km northeast of the La Coipa mine where Kinross announced a mining re-start in 2020; the second is Rio Loa, a project located 25 km south of Gold Field’s Salares Norte deposit (5.2 million ounces of Gold equivalent; the third and fourth projects are Alicia and Roma, which are approximately 35 km. south of the Salares Norte deposit. These exploration targets have been designated high priority due to extensive, pervasive alteration, favorable geology, and highly anomalous rock geochemical results and their relative proximity to existing deposits.For more information about the company, please visit www.GoldHavenResources.com. NOTE TO INVESTORS: The latest news and updates relating to GHVNF are available in the company’s newsroom at http://ibn.fm/GHVNF

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office www.InvestorWire.com [email protected]

InvestorWire is part of the InvestorBrandNetwork.

420 with CNW — Biden’s AG Nominee Reaffirms His Willingness to Respect States’ Cannabis Laws

March 8, 2021 04:25:41

The U.S. attorney general nominated by President Joe Biden stated in a written statement that the Department of Justice wouldn’t be using its resources to prosecute individuals who were in compliance with state cannabis laws.

Judge Merrick Garland explained that the government should focus on extensive criminal enterprises that do not comply with the state’s marijuana legalization…

NOTE TO INVESTORS: The latest news and updates relating to Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) are available in the company’s newsroom at http://cnw.fm/PACR

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Rhode Island Senate Passes Legislation Creating Safe Sites for Illicit Drug Users

March 5, 2021 16:25:00

Opioids initially gained popularity in the 1990s as doctors started prescribing prescription opioids to patients. Over the years, there has been a sharp increase in overdose-related deaths across the globe, from both prescribed and illicit drugs. To combat the growing opioid crisis, Australia, Canada, and some European countries established safe consumption sites (“SCS”) to help prevent overdose deaths and to provide substance-use disorder treatment to individuals.

The United States, however, doesn’t have a single safe consumption site, despite losing over 750,000 people from 1999–2018 to drug overdoses. However, the country may see its first-ever SCS if either of two bills in Rhode Island’s General Assembly passes. Initially introduced back in 2019, bills H 5245 and S 0016 would approve the creation of safe consumption sites in the state. According to Substance Use Policy, Education, and Recovery PAC co-chair Haley McKee, the bills…

NOTE TO INVESTORS: The latest news and updates relating to Gage Cannabis Co. are available in the company’s newsroom at https://cnw.fm/GAGE

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CNW420 is part of the InvestorBrandNetwork.

InvestorNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Showcases Virtual Event Platform Capabilities at Prestigious B. Riley Vision Day

March 5, 2021 15:28:57

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office www.InvestorWire.com [email protected]

InvestorWire is part of the InvestorBrandNetwork.

BioMedNewsBreaks – United Medical Equipment Business Solutions Network Inc. Offers Hi-Fi Masks, Other Essentials Amid Pandemic

March 5, 2021 14:04:45

United Medical Equipment (“UME,” “UMEBSNI”) is the distributor of a comprehensive line of COVID-19 products, including high-filtration (“hi-fi”) masks, the most effective in protecting against the pandemic. According to a recent article, the company offers a separate product line dedicated entirely to the needs of patients and health-care providers whose lives and work are impacted by the COVID-19 pandemic. This includes a wide range hi-fi masks as well as other products such as testing kits, sanitizers, gloves, face shields, thermometers and hoods. “Although shortages of PPE have eased somewhat compared to the start of the pandemic, many health care organizations are still concerned about maintaining their supply as these products remain in high demand,” the article reads. “As part of its efforts to provide essential PPE products during the pandemic, United Medical Equipment Business Solutions Network remains dedicated to serving this growing market need.”

To view the full article, visit https://ibn.fm/Uia8Q

About United Medical Equipment Business Solutions Network Inc.

United Medical Equipment Business Solutions Network offers reliable resources and solutions that are designed to meet the ever-changing needs of an aging population, which includes seniors and veterans. The company’s owners and founders bring decades of combined business, military and cardiovascular critical care nursing experience. United Medical Equipment understands the needs and concerns of the aging population, including veterans and their families, and offers the support, solutions and reliable information critical in making informed decisions. UMEs’ mission is to provide guidance for caregivers, veterans, the aging population and medical community through its medication management and telehealth applications by providing reliable resources, products and support services designed to meet unique needs. For more information, visit the company’s website at www.UnitedMedSolutions.com.

NOTE TO INVESTORS: The latest news and updates relating to UME are available in the company’s newsroom at https://ibn.fm/UnitedMed

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork

BioMedNewsBreaks – Brain Scientific Inc. (BRSF) Solution Holds Ability to Bridge the Gap in Neuro Testing

March 5, 2021 13:53:22

Brain Scientific (OTCQB: BRSF) is focused on modernizing brain diagnostics through cutting-edge technologies. The company’s NeuroCap(TM) offers a cost-effective, disposable solution that has the ability to bridge the gap in access to neurological testing. A recent article discussing this reads, “The NeuroCap has clear advantages to its bulkier EEG counterpart. The bulkier version requires a skilled specialist to administer, comes with metal disks and wires, requires constant cleaning and sterilization, and takes up to 30 minutes to administer, not including prep or cleaning time. With the NeuroCap, clinical personnel can apply the disposable headset in five minutes or less. This allows for EEGs to be administered in almost any location, including the patient’s home or nursing homes, assisted living facilities or clinics. In addition, because the cap is disposable, there is no need to sanitize after each use; the device is also compatible with conventional EEG amplifiers. The data can be reviewed and evaluated through third-party software, reducing the need for a neurologist to be on site.”

To view the full article, visit https://ibn.fm/lxHkT

About Brain Scientific Inc.

Brain Scientific is a commercial-stage health-care company with two FDA-cleared products, providing next-gen solutions to the neurology market. The company’s smart diagnostic devices and sensors simplify administration, shorten scan time and cut costs, allowing clinicians to make rapid decisions remotely and bridge the widening gap in access to neurological care. To learn more about the company’s corporate strategy, devices or for investor relations, visit www.BrainScientific.com.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork

Copper Demand Expected to Exceed Supply in 2021

March 5, 2021 13:48:41

Earlier in January, copper was trading at the highest price recorded in nearly eight years. The price of the metal increased in February with forecasts showing that this trend will continue in March. However, investors wager that as the world slowly recovers from the effects of the coronavirus pandemic, the supply tightness of copper will grow.

Senior StoneX metals analyst Natalie Scott-Gray predicts that this year the demand for copper will increase by roughly 5%, which will overtake the metal’s supply, which shortage…

NOTE TO INVESTORS: The latest news and updates relating to GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) are available in the company’s newsroom at http://ibn.fm/GHVNF

About MiningNewsWire

MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is part of the InvestorBrandNetwork.

Missouri Introduces Legislation to Add Psychedelics to “Right to Try” Statute

March 5, 2021 13:42:26

Residents of the state of Missouri living with terminal, life-threatening or debilitating ailments may soon be able to legally access various psychedelic drugs under a new bill, whose objective is to broaden Missouri’s current Right to Try statute.

A legislation introduced last month by Kansas City Republican Rep. Michael Davis would permit individuals who are seriously ill to use psychedelic substances such as ibogaine, MDMA, mescaline, psilocybin mushrooms, DMT and LSD, when all other approved treatment…

NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://ibn.fm/XPHYF

About PsychedelicNewsWire

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]

PsychedelicNewsWire is part of the InvestorBrandNetwork.

BioMedNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Bringing Effective Solutions to Vast Market

March 5, 2021 13:38:40

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, is engaged in establishing a new standard for the visualization of cancer during minimally invasive surgeries (“MIS”). The company is currently focused on bladder cancer, the most expensive cancer to treat due to a high 50% recurrence rate that leaves approximately 600,000 U.S. patients living in fear that their cancer will return. Imagin Medical’s i/Blue(TM) Imaging System has the ability to overcome limitations of today’s white and blue light cystoscopy procedures. The innovative technology enables surgeons to see real-time white and blue light images on the screen simultaneously during a procedure. This technology provides much promise in the visualization and removal of bladder cancer, the sixth most prevalent type of cancer in the United States. A recent article discussing this reads, “Led by a management team with significant experience in the market, both in medical device implementation and MIS, Imagin Medical is confident that its technology has the potential to revolutionize the current standard of care for bladder cancer patients, positioning the company as a leading provider of effective solutions in the vast market of bladder cancer visualization.”

To view the full article, visit https://ibn.fm/sGxy5

About Imagin Medical

Imagin Medical is a surgical imaging company focused on advancing new methods of visualizing cancer during minimally invasive procedures. The company believes its first product, the i/Blue(TM) Imaging System, with its proprietary optics and light sensors, will greatly increase the efficiency and accuracy of detecting cancer for removal, helping to reduce recurrence rates. The company’s initial focus is bladder cancer. For more information about the company, visit www.ImaginMedical.com.

NOTE TO INVESTORS: The latest news and updates relating to IMEXF are available in the company’s newsroom at https://ibn.fm/IMEXF

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork

Jaguar Pledges to Be All Electric by 2025

March 5, 2021 13:36:33

With several countries across the world looking to replace the combustion engine vehicles on their roads with zero-emission electric vehicles, most automakers have had to go back to the drawing board to figure out how they will exist in a world without combustion engines. Nissan, for instance, jumped onto the electric vehicle (“EV”) bandwagon years ago with the Nissan Leaf, while automakers such as General Motors have invested heavily in EV startups while still others have started electrifying their own lineups.

In that vein, Jaguar Land Rover has announced incoming changes to its Land Rover and Jaguar brands. Within the next five years, Land Rover will unveil six new all-electric vehicle models while Jaguar, its sister brand, will be overhauled into an all-electric luxury vehicle brand by 2025. According to Jaguar Land Rover (“JLR”), all of its brands will have electric versions by 2030 as part of a company-wide…

NOTE TO INVESTORS: The latest news and updates relating to Net Element (NASDAQ: NETE) are available in the company’s newsroom at http://ibn.fm/NETE

About Green Car Stocks

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
[email protected]

Green Car Stocks is part of the InvestorBrandNetwork.

InvestorNewsBreaks – Healthtech Solutions Inc.’s (HLTT) Mediscan Software Offers Convenient, Cost-Effective Imaging Alternative

March 5, 2021 13:36:30

Healthtech Solutions (OTC: HLTT), through its subsidiary Mediscan Inc., offers a software solution that is far cheaper than CT scans or X-rays and provides quality images for point-of-service medical professionals. “The company’s software specifically transforms ultrasound analog 2D grayscale images into digital 3D HD format that helps technicians derive data-driven insights into the condition of a patient… The software is cloud-based and easy to use anywhere there is an internet connection,” details an article on the innovation. “The Mediscan software application helps ultrasound technicians derive meaningful data-driven clinical evaluations of a patient’s pathology or trauma while facilitating support for treatment options. The software additionally enables health professionals to monitor the patient’s ongoing progress or regress while documenting compliance with required protocols and procedures… Along with vital organs like the heart, the technique can generate 3D medical images of other parts of the body such as the lungs, tendons, skin and nerves for analysis by emergency medical services (‘EMS’) and other health professionals such as primary care physicians, specialists, technical support staff and sports trainers.”

To view the full article, visit https://ibn.fm/T7MTY

Healthtech Solutions, Inc.

Healthtech Solutions, through its subsidiary, Mediscan Inc., offers technology that can transform 2D images from a portable ultrasound machine into digital 3D images to provide better diagnosis and more accurate internal trauma views. The technology has multiple applications in lung, cardiac and musculoskeletal imaging and related uses. For more information, visit the company’s website at www.MyMediScan.com.

NOTE TO INVESTORS: The latest news and updates relating to HLTT are available in the company’s newsroom at https://ibn.fm/HLTT

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

How Therapeutic Hypothermia Could Benefit ICU Patients

March 5, 2021 13:32:31

A recent study discovered how lower temperatures improved a surfactant’s activity, showing that therapeutic hypothermia is a possible treatment option for ARDS, which impacts roughly one-tenth of intensive care unit (“ICU”) patients globally. Apart from patients in ICUs, critical coronavirus patients also suffer from acute respiratory distress syndrome.

In layman’s language, therapeutic hypothermia is the intentional cooling of an individual’s body. Research conducted by Chiara Autilio and colleagues from the Jesus Perez-Gil laboratory at the Complutense University of Madrid demonstrates how therapeutic hypothermia works at the molecular level in an individual’s lungs; the research also notes how this method could effectively be applied to acute…

NOTE TO INVESTORS: The latest news and updates relating to AzurRx BioPharma Inc. (NASDAQ: AZRX) are available in the company’s newsroom at https://ibn.fm/AZRX

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork.

InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Announces Participation in Upcoming Investor Conferences

March 5, 2021 13:25:26

Trxade Group (NASDAQ: MEDS), a technology-enabled health services platform company focused on digitalizing the retail pharmacy experience, will be participating in three investor conferences scheduled in March 2021. In all three conferences, Trxade Group CEO Suren Ajjarapu will present valuable information and insights about the company for conference participants. In addition, he is scheduled to participate in one-on-one meetings during each event. Conferences in which Ajjarapu is scheduled to participate include the two-day H.C. Wainwright Global Life Sciences Conference, slated for March 9-10, 2021; the three-day Roth Growth Stock Conference, scheduled for March 15–17, 2021; and the two-day Maxim Group Emerging Growth Conference, which will be held March 17–18, 2021. All three conferences are virtual, online events.

To view the full press release, visit https://ibn.fm/c6MyX

About Trxade Group Inc.

Trxade Group is a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States. The company operates the TRxADE drug-procurement marketplace serving a total of 11,800-plus members nationwide and fostering price transparency as well as the Bonum Health brand, offering patient centric telehealth services. For more information about the company, please visit www.Trxade.com and www.BonumHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Announces Closing of Acquisition of Primordia Assets

March 5, 2021 13:12:48

Green Hygienics Holdings (OTCQB: GRYN) today announced that after months of negotiation and diligence, it has closed the acquisition of certain assets of Primordia, a seed-to-soil, single-origin hemp supply company, with a combination of cash and other future rights and entitlements. According to the update, Primordia will continue with its remaining operations under a different name but will not compete with Green Hygienics in this sector. “We are at the forefront of a growing, dynamic new sector within the biotech industry. The demand side continues to grow rapidly, while on the supply side the learning curve is steep and opportunities for valued acquisitions will arise,” said Green Hygienics CEO Ron Loudoun. “Our first e-commerce site is for the boutique brand Sol Valley Ranch, and the Primordia acquisition will target farm-direct bulk wholesale buyers. When you consider the improved ROI created through sales of finished product, it makes sense to develop or acquire a portfolio of e-commerce sites that target specific market segments. This acquisition will generate immediate cash flow for Green Hygienics.”

To view the full press release, visit https://cnw.fm/uqlSA

About Green Hygienics Holdings Inc.

Green Hygienics Holdings is a California-based, innovative, technology-driven enterprise focused on the high-standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The company’s corporate mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partner with CPG (consumer-packaged-goods) and pharmaceutical companies. Green Hygienics intends to be a leader in compliances and capabilities in the hemp and cannabinoid supply marketplace. Using state-of-the-art technologies, the company intends to open a whole new world of novel cannabinoids and targeted bio-delivery technologies never before explored, solving the issues of stability, pharmacokinetics, biological tissue penetration, and bioavailability. Green Hygienics is building a team of visionary agrotechnology, pharmaceutical and life scientists working at the intersection of nutraceutical, cosmeceutical and pharmaceutical technologies with a goal to improve lives. For more information, please visit the Corporate Video Link and www.GreenHygienics.com.

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://cnw.fm/GRYN

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is part of the InvestorBrandNetwork.

InvestorNewsBreaks – Moleculin Biotech Inc. (NASDAQ: MBRX) Secures $78M in Underwritten Public Offering

March 5, 2021 13:01:11

Moleculin Biotech (NASDAQ: MBRX), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, has closed an underwritten public offering of an aggregate of 16,414,736 shares of common stock, including an additional 2,141,052 shares per the full exercise of the over-allotment option granted to the underwriters. According to the update, Moleculin secured approximately $78 million in gross proceeds with each of the shares sold at the public offering price of $4.75. Moleculin Biotech intends to use the proceeds to fund its planned clinical trials, preclinical programs, for other research and development activities and for general corporate purposes. ROTH Capital Partners acted as co-manager for the offering.

To view the full press release, visit https://ibn.fm/WIyeZ

About Moleculin Biotech Inc.

Moleculin Biotech is a clinical-stage pharmaceutical company focused on the development of a broad portfolio of oncology drug candidates for the treatment of highly resistant tumors and viruses. The company’s clinical-stage drugs are: Annamycin, a next generation Anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity being studied for the treatment of relapsed or refractory acute myeloid leukemia (“AML”); WP1066, an immune/transcription modulator capable of inhibiting p-STAT3 and other oncogenic transcription factors while also stimulating a natural immune response, targeting brain tumors, pancreatic cancer and hematologic malignancies; and WP1220, an analog to WP1066, for the topical treatment of cutaneous T-cell lymphoma. Moleculin is also engaged in preclinical development of additional drug candidates, including other immune/transcription modulators, as well as WP1122 and related compounds capable of metabolism/glycosylation inhibition. For more information about the company, visit www.Moleculin.com.

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Gage Growth Corp. Announces Expansion of COOKIES Retail Footprint in Michigan

March 5, 2021 12:55:46

Gage Growth Corp. (d.b.a. Gage Cannabis), a leading high-quality cannabis brand and operator in Michigan, has announced that it will begin serving adult-use consumers at its second COOKIES provisioning center in Kalamazoo starting on Saturday, March 6, 2021. The move comes quickly after the COOKIES location in Kalamazoo opened its doors to serve all patients with a valid Michigan Medical Marijuana ID card in late February. COOKIES, an international cannabis lifestyle brand founded by rapper and entrepreneur Berner, opened its first Michigan location in January 2020. Gage is COOKIES’ exclusive partner in Michigan and operates the only COOKIES dispensaries in the Midwest. “We have been met with overwhelming demand since opening our first COOKIES location in Detroit last year and are eager to bring the acclaimed COOKIES experience to even more cannabis enthusiasts in the Midwest,” said Fabian Monaco, president of Gage. “This expansion is a testament to the market potential of Michigan’s cannabis industry, and we look forward to creating novel cannabis opportunities in partnership with COOKIES over the next year.”

To view the full press release, visit https://cnw.fm/7lDWV

About Gage Growth Corp.

Gage is innovating and curating the highest quality cannabis experiences possible for cannabis consumers in the state of Michigan and bringing internationally renowned brands to market. Through years of progressive industry experience, the firm’s founding partners have successfully built and grown operations with federal and state licenses, including cultivation, processing and retail locations. Gage’s portfolio includes city and state approvals for 19 “Class C” cultivation licenses, three processing licenses and 12 provisioning centers (dispensaries). For more information about the company, visit www.GageUSA.com.

NOTE TO INVESTORS: The latest news and updates relating to Gage are available in the company’s newsroom at https://cnw.fm/GAGE

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is part of the InvestorBrandNetwork.

Brain Scientific Inc. (BRSF) Making EEGs Accessible in Emergency Departments

March 5, 2021 12:37:59

Head CTs, MRIs are most-used but not most-effective tool for head trauma or neurological issues in triage
EEG changed clinical management of 76.2% of patients, even when CT or MRI was available
Brain Scientific has overcome key barriers causing EEG underuse in emergency medicine

Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company, is making EEGs accessible in emergency departments (“ED”) with cutting-edge tech that bridges the widening gap in access to quality care. As the public becomes more aware of head trauma’s long-term effects, triages fill up with potential TBIs and acute neurological conditions. Facilities are scrambling to adapt to the growing need but are often ill equipped to do so.

When a patient arrives presenting head trauma or neurological issues, almost reflexively, a head CT and/or MRI is ordered. A BRSF white paper titled “Electroencephalography in the Emergency Department” explains why this is not always the most…

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork.

Predictive Oncology Inc. (NASDAQ: POAI) Announces Fundraising Agreements to Raise Estimated $25M

March 5, 2021 12:23:26

POAI completes two separate fundraising initiatives: private placement, direct offering.
Two fundraising campaigns expected to result in $17.6 million, $7.4 million respectively.
Predictive Oncology plans to use funds to pay off debt as well as for working capital, general corporate purposes.

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has announced two funding initiatives that together total an estimated $25 million. The company has entered into securities purchase agreements with institutional and accredited investors (https://ibn.fm/WH4nw) to raise approximately $17.6 million and is involved in a direct offering that is expected to raise $7.4 million (https://ibn.fm/uSv23).

The securities purchase agreement was comprised of a total of 9,043,766 shares of common stock and warrants, offered at a purchase price of $1.95 per share. The private placement was expected to close around Feb. 22, 2021. In the announcement of the private placement, Predictive Oncology noted that it planned to use some $5.88 million of the net proceeds from the…

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork.

Uranium Energy Corp. (NYSE American: UEC) Positioned Favorably to Capitalize on Rising Uranium Demand

March 5, 2021 12:07:42

Increased nuclear power projects fueling rising demand for uranium
UEC controls one of the largest historical uranium exploration and development databases in United States
UEC property portfolio includes properties previously explored and developed by senior energy firms
UEC has fully licensed, low cost, ISR projects positioned to supply the U.S. Uranium Reserve
Nuclear energy included in Democratic Party’s energy platform for first time in 48 years

After spending a solid ten years in a downward trend, uranium stocks are now making fresh 52-week highs amid increased demand for energy (https://ibn.fm/GXF7e). Uranium Energy (NYSE American: UEC), a U.S.-based uranium mining and exploration company that controls one of the largest historical uranium exploration and development databases in the United States, is positioned to benefit from the trend after having acquired multiple mining sites in North and South America that allow the company to target specific uranium-rich areas.

Increased global demand for nuclear energy continues to drive the demand for uranium while long-term supplies are becoming less certain. Analyst Lyn Alden Schwartzer of Seeking Alpha predicts robust and increasing demand for uranium from developing nations and manufacturing powerhouses like China that continue to…

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC

About MiningNewsWire

MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) Shifts into Growth Mode with Recent Fundraising, Acquisition Announcements

March 5, 2021 11:43:26

Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF), a Portland-based cannabis company widely recognized for its Chalice Farms stores and products has raised approximately $8.7 million and recently signed a letter of intent to acquire a store chain in Northwest Oregon, both indications that the company is shifting into a growth mode with a focus on Oregon markets. In a recent article, Golden Leaf Holdings CEO Jeff Yapp noted that the company was waiting to reveal the name of the chain of store pending a definitive purchase agreement. When the deal goes through, Yapp noted, GLH will use monies from recent fundraising, along with stock and a promissory note, to complete the transaction; the stores could conceivably bring in an at least $10 million annually. The article noted that a series of restructuring moves, a cash-flow positive quarter from operations for the first time and consecutive record-breaking quarters last year have revived investor interest in the company, which also distributes products in California, Nevada and Washington. “Our focus has been on the operating fundamentals and earning credibility,” said Golden Leaf Holdings CEO Jeff Yapp in the article. “That got us to the place where we had a base of revenue that allowed us to operate on a profitable basis. So the question became, how do we accelerate growth? . . . Oregon is undervalued by the industry. People see it as oversaturated, over supplied, but Oregon as a leadership market is very interesting. We think it’s a bellwether state.”

To view the full article, visit https://cnw.fm/zEYg2

About Golden Leaf Holdings Ltd.

NOTE TO INVESTORS: The latest news and updates relating to GLDFF are available in the company’s newsroom at https://cnw.fm/GLDFF

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is part of the InvestorBrandNetwork.

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) and WPD Pharmaceuticals (CSE: WBIO) (Frankfurt: 8SV1) Get the Green Light for Clinical Trials’ Protocols from Ethics Panels

March 5, 2021 11:16:24

CNS Pharmaceuticals holds the exclusive worldwide license to the Berubicin chemical compound
Berubicin is CNSP’s lead, novel anthracycline candidate for the treatment of glioblastoma multiforme (“GBM”) that was the subject of a previously conducted Phase 1 clinical trial, which had a clinical benefit response rate of 44%
CNSP has sublicensed Berubicin to WPD Pharmaceuticals in 31 countries primarily in eastern Europe and western Asia
WPD plans to conduct a Phase 2 trial in adults with GBM and a Phase 1 trial for pediatric patients with malignant gliomas
CNSP intends to conduct its own Phase 2, potentially pivotal, trial in s GBM patients who have failed first-line therapy and is on track to commence the study in March 2021
Both WPD and CNSP have received favorable opinions for their respective protocols to be used in their clinical trials

The Lower Silesian Medical Chamber Ethics Committee in Wroclaw, Poland recently gave WPD Pharmaceuticals (CSE: WBIO) (Frankfurt: 8SV1) (“WPD”), CNS Pharmaceuticals, Inc.’s (NASDAQ: CNSP) sublicensee in Europe and Asia for Berubicin, a positive opinion for its WPD-201 Clinical Trial Protocol to be used in the planned forthcoming Berubicin clinical trial in adults with glioblastoma multiforme (“GBM”).

Notably, a regulatory body within a given territory – in this case, Poland – shares a positive opinion to ascertain that a study, through its protocol, respects participants’ dignity, rights, safety, and…

NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork.

Wild West Crypto Show Features Back to the Basics and Cowboy Logic on Cryptocurrencies

March 5, 2021 10:59:12

Conservative alt-coin podcast hosts Drew Taylor and Brent Bates recently welcomed guests and the audience to a lively episode of their wildly popular Wild West Crypto Show. In a recent episode, the hosts welcomed CryptoCurrencyWire’s Jonathan Keim to shine a spotlight on the latest and greatest happenings in the world of cryptos. Taylor and Bates also covered the ongoing run on cryptos, a new milestone reached with cryptocurrency surpassing 100 million users for adoption, and took it back to the basics on cryptocurrency to discuss basic terminologies and whether it’s a “21st century unicorn” or the money of the future. “You know what this reminds me of?” Taylor said, offering a cowboy analogy on the ability to get in on cryptos. “Years ago, we were elk hunting in Chama, New Mexico. We’d gone up there, taken our mules up there and we’d gone up on the trailhead… And, mules are different than horses, we hobbled the mules… You can hobble a horse, and it won’t run… But we hobbled the mules, and mules learn to run like a rabbit. So they’re running down the trailhead, and it was like bitcoin running. We were so happy when they got a little bit tired out so we could catch them.”

To watch the latest episode, visit https://ccw.fm/NxDKi

About Wild West Crypto Show

The Wild West Crypto Show appears on TV in multiple markets across the country as well as online as a humorous and educational forum for providing information with the intent of reducing some of the consumer wariness about alt currency. For more information about the show and to view the latest episode, which includes CryptoCurrencyWire’s ongoing segment featuring recent news from around the world, visit www.WildWestCryptoShow.com.

About CryptoCurrencyWire (“CCW”)

To receive instant SMS alerts, text CRYPTO to 77948 (U.S. Mobile Phones Only)

CryptoCurrencyNewsWire is where News, content and information converge via Crypto.

For more information, please visit https://www.CryptoCurrencyWire.com

Please see full terms of use and disclaimers on the CryptoCurrencyWire (CCW) website applicable to all content provided by CCW, wherever published or re-published: http://CCW.fm/Disclaimer

CryptoCurrencyWire (CCW)
New York, New York
www.CryptoCurrencyWire.com
212.994.9818 Office
[email protected]

CryptoCurrencyWire is part of the InvestorBrandNetwork.

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Establishes Clinical Advisory Board to Help Drive Growth

March 5, 2021 10:46:48

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing including obstructive sleep apnea (“OSA”), announced the creation of its new Clinical Advisory Board. The six-member board will focus on driving adoption and growth of Vivos’ next-gen treatments for OSA. Reports indicate that an estimated 1 billion people around the world struggle with OSA. Members of Vivos’ new board include the following: neurologist and sleep specialist Clete A. Kushida, MD, PhD; nationally recognized key opinion leader Edward Zuckerberg, DDS; co-founder of the American Academy of Physiological Medicine and Dentistry Michael Gelb, DDS, MS; board-certified sleep specialist and pediatric pulmonologist Manisha Witmans, MD, FAASM; private practitioner in craniofacial sleep medicine and dentistry Tammarie Heit, DDS, MICCMO, RN; and American Sleep and Breathing Academy Diplomate Jon Caulfield, DDS. “In forming Vivos’ new Clinical Advisory Board, we sought out the world’s leading minds in the sleep medicine and dentistry fields,” said Vivos Therapeutics chairman and CEO Kirk Huntsman in the press release. “Each member holds the highest level of credentials and brings decades of combined experience to the table. They are charged with ensuring that our Vivos System technology remains at the forefront of treatment for patients continuing to suffer from sleep apnea across the U.S.”

To view the full press release, visit https://ibn.fm/22ezG

About Vivos Therapeutics Inc.

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

InvestorNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Reaches Milestone: Ladenburg Thalmann & Co. Inc. Signs Market Maker Intention Letter

March 5, 2021 10:09:35

Kaival Brands Innovations Group (OTCQB: KAVL), a company focused on generating shareholder value by incubating innovative products into mature and dominant brands within their respective markets, has met a significant requirement in the process of uplisting to the Nasdaq. The company has announced that Ladenburg Thalmann & Co. Inc. has signed a market maker intention letter, indicating its commitment to make a market in Kaival shares when listed on the Nasdaq. Kaival Brans is the exclusive global distributor of all products manufactured by Bidi Vapor LLC; the Bidi(R) Stick is the fastest-growing closed system vaping product in the country and is the only vape product on the market with an ecologically friendly, mass-recycling program called Bidi(R) Cares. Combined with the other market maker commitments Kaival has obtained, Ladenburg Thalmann’s intention letter allows Kaival Brands to meet the Nasdaq market maker requirement. Ladenburg Thalmann comprises more than 4,000 financial advisors in its network and touts a rich 140-year history. “We are extremely excited and grateful to have the venerable firm, Ladenburg Thalmann, committed to making efficient and productive markets for shares of Kaival,” the company stated in the press release. “We feel as though our shareholders are all family and this is a big step towards uplisting on Nasdaq. We feel fortunate to be able to entrust our company shares to the very capable hands of these sophisticated financial traders and their tremendous retail reach.”

To view the full press release, visit https://ibn.fm/mdMKs

About Kaival Brands Innovations Group Inc.

Kaival Brands is focused on growing and incubating innovative and profitable products into mature and dominant brands in their respective markets. Kaival’s vision is to develop internally, acquire, own or exclusively distribute these innovative products and grow each into dominant market-share brands with superior quality and recognizable innovation. For more information, visit the company’s website at www.KaivalBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to KAVL are available in the company’s newsroom at http://ibn.fm/KAVL

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

BioMedNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Participate in Upcoming Stephens Best Ideas Conference

March 5, 2021 09:59:39

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics (“DTx”) market, has been selected to participate in the virtual Stephens 2021 Best Ideas Conference. The conference is slated for March 11, 2021. As part of that participation, Dario CEO Erez Raphael and president/general manager Rick Anderson will presenting. Their presentation is scheduled to begin at 9 a.m. ET on March 11; a replay of their presentation will be available following the conference. DarioHealth is committed to change how people with chronic conditions manage their health. The company has one of the highest-rated diabetes and hypertension solutions on the market and is focused on providing next-generation, AI-powered, digital therapeutic solutions in the health-care space.

To view the live or archived webcast, visit https://ibn.fm/mSUQe

To view the full press release, visit https://ibn.fm/8f5bP

About DarioHealth Corp.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork

InvestorNewsBreaks – Augusta Gold Corp. (OTCQB: AUGG) (CSE: G) (FSE: 11B) Announces Closing of Private Placement, Gross Proceeds Total C$17 Million

March 5, 2021 09:29:53

Augusta Gold Corp.(OTCQB: AUGG) (CSE: G) (FSE: 11B) has closed on its nonbrokered private placement, a move that resulted in gross proceeds of approximately C$17 million for the company. Announced earlier, the placement included 7.56 million units, which were sold at C$2.25 per unit. Each unit in the private placement was made up of one common share of the company and one-half of one common share purchase warrant, with each full warrant enabling the holder to acquire an additional common share over the next three years, at an exercise price of C$2.80. The company noted that it intends to use the net proceeds from the private placement to advance exploration efforts at its wholly owned Bullfrog Gold project located in Nevada as well as for general and working capital purposes. The announcement reported that the placement was subscribed by insiders including Richard Warke and other strategic investors. “We are very grateful for the solid support from Mr. Warke and the additional strategic investors that participated as we pursue our vision to unlock value from the Bullfrog Gold project through a systematic approach to our exploration and development program,” said August Gold president and CEO Maryse Belanger in the press release. “This financing provides the funds to fully execute on our 2021 programs including undertaking a drill program in excess of 85,000 metres and de-risking the project through environmental, permitting and engineering work.” To view the full press release, visit https://ibn.fm/nwPPf About Augusta Gold Corp Augusta Gold is a rapidly growing exploration and development company focused on building a long-term business that delivers stakeholder value through developing the Bullfrog Gold Project and pursing accretive M&A opportunities. The Bullfrog Gold Project is located in the prolific Bullfrog district approximately 120 miles northwest of Las Vegas, Nevada, and four miles west of Beatty, Nevada. The company controls approximately 7,800 acres of mineral rights including the Bullfrog and Montgomery-Shoshone deposits and has further identified significant additional mineralization around the existing pits and defined several exploration targets that could further enhance the project. The company is led by a management team and board of directors with a proven track record of success in financing and developing mining assets and delivering shareholder value. For more information about this company, visit www.AugustaGold.com. NOTE TO INVESTORS: The latest news and updates relating to AUGG are available in the company’s newsroom at https://ibn.fm/AUGG

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office www.InvestorWire.com [email protected]

InvestorWire is part of the InvestorBrandNetwork.

420 with CNW — Washington State Supreme Court Repeals Law Criminalizing Drug Possession

March 5, 2021 04:25:18

The Washington State Supreme Court recently nullified the state’s criminal penalties against drug possession, terming them unconstitutional. This was followed by some prosecutors and police departments in the state announcing that they’d no longer pursue cases of possession or arrest individuals over the possession of small amounts of drugs.

The Seattle Police Department issued a public statement that stated that simple drug possession was no longer deemed to be an arrestable offense, adding that effective immediately, officers in the department…

NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://cnw.fm/XPHYF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Michigan Rolls Back Key Recreational Cannabis Business License Restriction

March 4, 2021 16:34:19

After months of restricting access to its recreational cannabis industry, Michigan has loosened a key restriction that kept many from acquiring a recreational cannabis license. Beginning on March 1, 2021, applicants for five types of recreational cannabis licenses will not be required to have an active medical marijuana license to qualify. The state initially put this policy in place to allow the companies that first invested in cannabis to become established and recoup their costs before the industry was filled with sellers, says the director of the Michigan Cannabis Industry Association.

Although the requirement was supposed to remain active for two years after the state began issuing recreational cannabis licenses, cannabis legislation passed by voters in 2018 said the state could remove the prerequisite after a year to fight black market sales, address reduced supply…

NOTE TO INVESTORS: The latest news and updates relating to Green Hygienics Holdings Inc. (OTCQB: GRYN) are available in the company’s newsroom at http://cnw.fm/GRYN

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CNW420 is part of the InvestorBrandNetwork.

InvestorNewsBreaks – Ideanomics (NASDAQ: IDEX) Enters Investment Agreement with Energica Motor Company S.p.A

March 4, 2021 15:30:28

Ideanomics (NASDAQ: IDEX), on March 3, 2021, entered into an investment agreement with Energica Motor Company S.p.A pursuant to which Ideanomics invested Euro 10,909,091 for 6,128,703 ordinary shares of Energica at a subscription price of Euro 1.78 for each ordinary share. Upon purchase of the shares, Ideanomics will hold at least 20% of Energica’s share capital. Energica is the world’s leading manufacturer of high-performance electric motorcycles and the sole manufacturer of the FIM Enel MotoE(TM) World Cup. “We are proud to be part of this unified platform of which we fully share the vision,” said Livia Cevolini, CEO of Energica, of the investment. “The creation of a network of innovative companies can only accelerate the growth and adoption of new technologies such as sustainable mobility that sees us among the leaders. We are confident to make our contribution derived from decades of experience in the field of high-performing electric motorcycles. The investment will give further strength to the Energica growth already underway in recent years thanks to the innovations brought to our products within the racing experience in MotoE.” For more details, visit https://ibn.fm/Q1qtS About Ideanomics Ideanomics is a global company that facilitates the adoption of commercial electric vehicles and supports next-generation financial services and fintech products. Its electric vehicle division, Mobile Energy Global (“MEG”) provides group purchasing discounts on commercial electric vehicles, EV batteries and electricity, as well as financing and charging solutions; the company refers to this business model as sales to financing to charging (“S2F2C”). Ideanomics Capital provides fintech services that include intelligent and innovative solutions powered by AI and blockchain. Together, MEG and Ideanomics Capital provide global customers and partners with more efficient solutions for a greener economy. The company is headquartered in New York City, New York, with offices in Beijing, Hangzhou and Qingdao and operations in the U.S., China, Ukraine, and Malaysia. For more information, visit www.Ideanomics.com. NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office www.InvestorWire.com [email protected]

InvestorWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Gage Cannabis Co. President Featured Guest on Gamechangers LIVE Interview

March 4, 2021 15:19:42

Gage Growth Corp. (d.b.a. Gage Cannabis) president and director Fabian Monaco recently appeared on Gamechangers LIVE, a podcast series that features individuals who are gamechangers in their fields. During the podcast, which is hosted by Sergio Tigera, guests talk about their journeys and share their mindsets, struggles and successes in an effort to both inspire and inform listeners. During the interview, Monaco discussed Gage’s recent closing of its oversubscribed Regulation A+, Tier 2, equity financing that totaled $50 million, the maximum amount allowed under the company’s offering. Monaco talked about the financing, referencing his extensive background in investment banking and capital markets; he also noted that Gage plans an upcoming initial public offering. Monaco also provided additional insights about the future of the cannabis industry, including the challenges cannabis companies regarding U.S. banking regulations. He also outlined why now is the ideal time for anyone — investors as well as anyone looking for a career in a sector with promising growth — to get into the industry. “The industry continues to move in a positive direction,” said Gage Cannabis president and director Fabian Monaco in the press release. “Right now, it’s probably the most positive it has ever been. I think we’re going to see explosive growth. If you look at the U.S., I think it’s going to be crazy in terms of the growth this year. You’re frequently thrown a curveball in this industry. Things you think will happen fast end up being slow. Things you think are going to be slow end up happening fast. It’s like constantly being on the treadmill at super high speed, just trying to make sure you don’t fall off.”

To view the full interview, visit https://cnw.fm/atdVM

To view the full press release, visit https://cnw.fm/QEMBN

About Gage Cannabis Co.

Gage Cannabis is innovating and curating the highest-quality cannabis experiences possible for cannabis consumers in the state of Michigan and bringing internationally renowned brands to market. Through years of progressive industry experience, the firm’s founding partners have successfully built and grown operations with federal and state licenses, including cultivation, processing and retail locations. Gage’s portfolio includes city and state approvals for 19 Class C cultivation licenses, three processing licenses and 12 provisioning centers (dispensaries). For more information, visit the company website at www.GageUSA.com.

NOTE TO INVESTORS: The latest news and updates relating to GAGE are available in the company’s newsroom at https://cnw.fm/GAGE

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is part of the InvestorBrandNetwork.

Cross-Border Mining Sector Deals Total $2.4B in Last Quarter of 2020 in North America

March 4, 2021 15:08:59

While the average of the last four quarters had 43 cross-border deals, 2020’s final quarter announced 40 cross-border deals in the region, which were valued…

NOTE TO INVESTORS: The latest news and updates relating to Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) are available in the company’s newsroom at http://ibn.fm/UUUU

About MiningNewsWire

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is part of the InvestorBrandNetwork.

InvestorNewsBreaks – Mobius Interactive Ltd. Eyes Numerous Opportunities in Continued Growth

March 4, 2021 15:00:55

Mobius Interactive, an online gaming operator featuring unique offerings for diverse demographic groups, is positioned for continued growth on the heels of multiple 2020 milestones. These include the company’s launch of three diverse brands that include Mobius Bet, Aragon Casino and Club Double. A recent article discussing this reads, “As the company continues to grow, it is eyeing numerous opportunities, including the following: Movement forward on deals with E-sports tournament companies that desire to showcase their tournaments on the company websites; plans in place to provide services in as many Latin American countries as possible; enter and go public on exchanges in Canada, the UK and Europe; and raise funds to enter the competitive and challenging U.S. market.”

To view the full article, visit https://ibn.fm/G9Ghc

About Mobius Interactive Ltd.

Mobius Interactive is an online gaming operator with a variety of unique offerings catering to diverse demographic groups. Mobius Interactive’s team has extensive senior-management experience across business-to-consumer (“B2C”) and business-to-business (“B2B”) marketing in the iGaming industry, specializing in eSports, sports betting, casino and live casino. In partnership with leading eSports and iGaming platform Ultra Play, Mobius Interactive seeks to attract a network of high-net-worth gamers from around the world. Mobius does this through the use of loyalty and gamification programs designed to enhance engagement by leveraging state-of-the-art customer-relationship management systems and joint ventures with more than 600 VIP and master gaming affiliates. For more information, visit the company’s website at www.MobiusInteractive.Ltd.

NOTE TO INVESTORS: The latest news and updates relating to Mobius are available in the company’s newsroom at http://ibn.fm/Mobius

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

EV Maker Lucid to Go Public after Completing $12B Deal

March 4, 2021 14:59:57

Lucid Motors, an American manufacturer of electric vehicles (“EVs”), is set to go public after completing a merger with Churchill IV Capital Corp. (NYSE: CCIV). The merger deal is worth $11.75 billion.

The EV maker is run by Peter Rawlinson, who formerly worked as an engineer for Tesla Inc. (NASDAQ: TSLA). Lucid comes as the most recent EV maker to enter the IPO market at a time when investors are flocking to the electric vehicle sector after seeing the way in which the shares of Tesla…

About Green Car Stocks

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
[email protected]

Green Car Stocks is part of the InvestorBrandNetwork.

Why Companies Should Manufacture Psychedelic Pharmaceuticals on Large Scale

March 4, 2021 14:49:33

The development of a new class of pharmaceutical medications made from psychedelic fungi and plants has brought medical science closer to making breakthroughs that address the global mental health crisis caused by the pandemic. These drugs have shown massive potential in the treatment of chronic depression.

However, there are challenges that come with the development of standardized organic compounds to help treat more than a billion individuals…

NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) (OTC: CLXPF) are available in the company’s newsroom at https://ibn.fm/CYBN

About PsychedelicNewsWire

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]

PsychedelicNewsWire is part of the InvestorBrandNetwork.

MiningNewsBreaks – Why Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) Is ‘One to Watch’

March 4, 2021 14:43:24

Excellon Resources (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) is a producer of silver and base metals with precious metal exploration and development projects in Mexico, Idaho and Germany. Since its 1987 founding, the company has been advancing a precious metals growth pipeline focused on creating wealth for its stakeholders by realizing strategic opportunities in the silver and gold markets. A recent article discussing the company reads, “Excellon is an active and influential member of the Mining Association of Canada (‘MAC’). The company implements a practical, best-in-class management system that addresses the safety, health, security, environmental and community aspects of its operations, per the UN Sustainable Development Goals. On each project, Excellon Resources incorporates MAC’s Towards Sustainable Mining Initiatives and other world-class best practices with the objective of constantly improving its safety systems, training and hazard recognition.”

To view the full article, visit https://ibn.fm/dgkNJ

About Excellon Resources Inc.

Excellon’s vision is to create wealth by realizing strategic opportunities through discipline and innovation for the benefit of its employees, communities and shareholders. The company is advancing a precious metals growth pipeline that includes: Platosa, Mexico’s highest-grade silver mine since production commenced in 2005; Kilgore, a high-quality gold development project in Idaho with strong economics and significant growth and discovery potential; and an option on Silver City, a high-grade epithermal silver district in Saxony, Germany with 750 years of mining history and no modern exploration. The company also aims to continue capitalizing on current market conditions by acquiring undervalued projects. Additional details on Excellon’s properties are available at www.ExcellonResources.com.

NOTE TO INVESTORS: The latest news and updates relating to EXN are available in the company’s newsroom at https://ibn.fm/EXN

About MiningNewsWire

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is part of the InvestorBrandNetwork.

Researchers Design New Device That Uses Body as a Battery

March 4, 2021 14:43:03

CU Boulder researchers have designed a low-cost wearable device that uses the human body as a biological battery. The device is made of a stretchy material that allows an individual to wear it as a bracelet, ring or other accessory. The device harnesses an individual’s natural heat and uses thermoelectric generators to turn the internal temperature of an individual’s body into electricity. The paper was published in the “Science Advances” journal.

Associate professor at the Paul M. Rady Department of Mechanical Engineering, Jianliang Xiao, who is also the paper’s senior author, stated that the future objective of the researchers is to be able to design a wearable electronic that doesn’t require a battery to work. The device designed…

NOTE TO INVESTORS: The latest news and updates relating to Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) are available in the company’s newsroom at https://ibn.fm/IMEXF

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork.

InvestorNewsBreaks – Weebit Nano Ltd (ASX: WBT) Announces Plans to Attend 33rd Annual ROTH Growth Conference

March 4, 2021 14:41:41

Weebit Nano (ASX: WBT), a leading developer of next-generation semiconductor memory technology, today announced that its CEO Coby Hanoch will attend the 33rd Annual ROTH Growth Conference. The event, slated to take place virtually from March 15 – 17, 2021, will feature presentations from public and private companies across a variety of industry sectors. Hanoch will hold one-on-one investor meetings throughout the conference, during which he will present the company’s vision for the future of semiconductor memory, as well as its development milestones, plans and progress toward commercialization. Interested parties should contact their ROTH representative to schedule a virtual one-on-one meeting with Weebit management during the event. To view the full press release, visit https://ibn.fm/k45Qr About Weebit Nano Ltd. Weebit Nano is a leading developer of next-generation semiconductor memory technology. The company’s ground-breaking Resistive RAM (“ReRAM”) addresses the growing need for significantly higher performance and lower power memory solutions in a range of new electronic products such as internet-of-things (“IoT”) devices, smartphones, robotics, autonomous vehicles, 5G communications and artificial intelligence. Weebit’s ReRAM allows semiconductor memory elements to be significantly faster, less expensive, more reliable and more energy efficient than those using existing Flash memory solutions. Because it is based on fab-friendly materials, the technology can be quickly and easily integrated with existing flows and processes, without the need for special equipment or large investments. For more information, visit www.Weebit-Nano.com.

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office www.InvestorWire.com [email protected]

InvestorWire is part of the InvestorBrandNetwork.

BioMedNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Leveraging AI, Proprietary Database to Improve Outcomes for Patients of Today and Tomorrow

March 4, 2021 14:28:20

Predictive Oncology (NASDAQ: POAI), a knowledge-driven medicine company focused on applying data and artificial intelligence (“AI”) to cancer personalized medicine and drug discovery, has been a forerunner in the field, helping oncologists individualize cancer treatment through its Helomics division. A recent article discussing this reads, “Predictive Oncology is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through its Helomics division, the company leverages its unique, clinically validated patient derived (“PDx”) smart tumor profiling platform to provide oncologists with a roadmap to help individualize therapy. In addition, the company is leveraging artificial intelligence and its proprietary database of over 150,000 cancer cases tumors to build AI-driven models of tumor drug response to improve outcomes for the patients of today and tomorrow.”

To view the full article, visit https://ibn.fm/qGVfn

About Predictive Oncology Inc.

Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. TumorGenesis Inc. specializes in media that help cancer cells grow and retain their DNA/RNA and proteomic signatures, providing researchers with a tool to expand and study cancer cell types found in tumors of the blood and organ systems of all mammals, including humans. Skyline Medical markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. Soluble Biotech is a provider of soluble and stable formulations for proteins including vaccines, antibodies, large and small proteins and protein complexes. For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork

GreenCarNewsBreaks – Tesla Inc. (NASDAQ: TSLA) Featured in Simply Wall St Journal

March 4, 2021 14:24:03

Tesla (NASDAQ: TSLA), an American electric vehicle (“EV”) and clean energy company, was featured in this week’s Simply Wall St Journal that discussed its valuation and a split of believers and skeptics as to its limitless value versus those more pessimistic on its prospects. The article clarifies Tesla’s current standing and what the company needs to do to achieve its ambitious targets. “Tesla (NASDAQ: TSLA) is easily one of the most controversial companies in the world right now. Most either love it or hate it. These two groups seem to be split into those who owned it through 2020, and those who watched on the sidelines as the price multiplied 10-fold,” the piece reads. “What’s undeniable is the fact that Tesla is working on some exciting innovation in the world’s transition to sustainable energy. The company’s grand ambitions for electric vehicles, autonomous driving, battery design, energy storage and energy generation have contributed to the widely differing opinions on the business’ future. Some believe its plans are possible, while others are skeptical.” For more details, visit https://ibn.fm/6zjP9 About Tesla Inc. Tesla is an American electric vehicle (“EV”) and clean energy company. Tesla’s current products include electric cars, battery energy storage from home-to-grid scale, solar panels and solar roof tiles, as well as other related products and services. Tesla was ranked as the world’s best-selling plug-in and battery electric passenger car manufacturer in 2019, with a market share of 17% of the plug-in segment and 23% of the battery electric segment. Through its subsidiary SolarCity, Tesla develops and is a major installer of solar photovoltaic systems in the United States. Tesla is also one of the largest global suppliers of battery energy storage systems, with 3 GWh of battery storage supplied in 2020, and has installed some of the largest battery storage plants in the world. For more information, visit www.Tesla.com. About Green Car Stocks Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge. To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only) For more information, please visit https://www.GreenCarStocks.com Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer Green Car Stocks San Francisco, California www.GreenCarStocks.com 415.949.5050 Office [email protected] Green Car Stocks is part of the InvestorBrandNetwork.

BioMedNewsBreaks – VistaGen Therapeutics Inc.’s (NASDAQ: VTGN) Pipeline Holds Potential to Go Beyond Standard of Care for Anxiety, Depression

March 4, 2021 14:14:25

VistaGen Therapeutics (NASDAQ: VTGN) is a biopharmaceutical company committed to developing a new generation of medications that go beyond the standard of care for anxiety and depression. A recent article discussing this reads, “Depression and anxiety are at the forefront of concern for VistaGen, a company working to develop innovative product candidates to address these substantial issues. For example, FDA-approved oral antidepressants are slow to act and are associated with significant potential side effects such as anxiety, nausea and vomiting, somnolence and sexual dysfunction. VistaGen’s PH10 is an innovative pherine nasal spray designed to have rapid-onset therapeutic potential in several neuropsychiatric indications involving depression. Following completion of successful exploratory Phase 2A clinical development, the company is preparing to launch a planned Phase 2B clinical study of PH10 in major depressive disorder in early 2022. With its rapid-onset pharmacology, potential lack of systemic exposure and favorable safety results observed in all clinical studies to date, PH10 has potential to go beyond the current standard of care for depression as a novel stand-alone treatment for multiple depression disorders.”

To view the full article, visit https://ibn.fm/X5Pkn

About VistaGen Therapeutics Inc.

VistaGen is a biopharmaceutical company committed to developing and commercializing innovative medicines with potential to go beyond the current standard of care for anxiety, depression and other CNS disorders. Each of VistaGen’s three drug candidates has a differentiated potential mechanism of action, has been well-tolerated in all clinical studies to date and has therapeutic potential in multiple CNS markets. For more information, please visit www.VistaGen.com and connect with VistaGen on Twitter, LinkedIn and Facebook.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork

InvestorNewsBreaks – InvestorBrandNetwork (‘IBN’) Announces Continued Collaboration for Upcoming Virtual ROTH Conference

March 4, 2021 14:08:53

InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment community through 50+ brands such as InvestorWire, today announced that it will continue its collaboration with the ROTH Conference on the occasion of its upcoming 33rd annual investor event. The conference is slated to be held in an entirely virtual format from March 15-17, 2021. Well known as one of the nation’s largest investor conferences for small and mid-cap listed companies, this year’s virtual event promises to be exceptional, featuring hundreds of innovative and cutting-edge growth companies. The event will also host thematic sector panels and thousands of management one-on-one meetings. IBN is returning as a sponsor for the 11th year and will further the distribution of content generated for the event in addition to participating in a panel presentation to attending delegates. “Our team is excited to be working once again with the organizers of the ROTH Conference, which has earned a well-deserved reputation for connecting some of the world’s most innovative small and medium-cap companies to thousands of investors,” said Jonathan Keim, communications director for IBN. “We are leveraging our communications solutions to heighten visibility in advance of the event and will also widen the reach of each company presentation delivered.” To view the full press release, visit https://ibn.fm/KSq8j About ROTH Capital Partners ROTH is an investment banking firm dedicated to the small-cap public market and is headquartered in Newport Beach, California. ROTH is a privately owned firm that has built a culture of success and innovation. Its approach is driven by the firm’s current principals, who are not only the owners of the business but most of whom have been with ROTH for more than 20 years. ROTH’s goal has always been to service the needs of small-cap public companies better than anyone else. For more information about the ROTH Conference, visit www.ROTH.com/OC2021Virtual.

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office www.InvestorWire.com [email protected]

InvestorWire is part of the InvestorBrandNetwork.

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) CEO Talks About Recent Formation of Food Industry Consortium in “Emerging Technology Insider” Video

March 4, 2021 13:45:02

Pressure BioSciences (OTCQB: PBIO) (“PBI”) founder, president and CEO Ric Schumacher was a guest on a recent episode of “Emerging Technology Insider,” which regularly releases video conversations with management of technology companies with business or financial objectives. During the interview, Schumacher focused on the company’s recently announced food industry consortium partnership with The Ohio State University and the impact it may have on the food industry. The agreement between PBI and the College of Food, Agricultural, and Environmental Sciences at Ohio State calls for PBI to install several models of its patented Ultra Shear Technology(TM) (“UST”) platform in the state-of-the-art Ohio State food pilot plant. The plant provides careful temperature and pressure control. During the interview, Schumacher noted that members of the consortium will have first access to the UST test systems and food applications developed in the pilot plant, including licensing opportunities to leverage new applications of PBI’s UST platform and other consortium-developed IP. Schumacher also noted several primary goals and benefits for food companies that join the consortium, which will be comprised of many global, well-known, leading food and beverage companies from around the world. For instance, UST, which is PBI’s proprietary method for homogenizing immiscible liquids, could potentially result in the availability of food that offers greater safety, improved absorption, better taste/smell/texture, longer room temperature shelf life and more “clean labels” (reduced or no unwanted chemical additives). The consortium will focus on advancing the commercialization of PBI’s UST platform through the quality enhancement of beverages and liquid foods, including many dairy products, condiments and sauces. The group will also focus on identifying methods to reduce costs of processing, shipping, distribution, storage and spoilage through extended room temperature stability, without compromising quality or sensory experience of the products. To view the full press release, visit https://ibn.fm/cMHra About Pressure BioSciences Inc. Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. PBIO’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented-enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). The company’s primary focus is on the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of PBIO’s pressure-based technologies in the following areas: (1) the use of its recently acquired, patented technology from BaroFold Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) the use of its recently patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room-temperature, stable, low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. For more information, visit the company website at www.PressureBioSciences.com. NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office www.InvestorWire.com [email protected]

InvestorWire is part of the InvestorBrandNetwork.

RYAH Group Committed to Advancing Telehealth in HIPAA-Compliant Environment

March 4, 2021 13:32:28

Telehealth sector going through explosive growth; patients’ data protection remains key challenge
Although relaxed due to COVID-19 outbreak, HIPAA guidelines protecting patients’ data security, privacy likely to tighten as pandemic abates
RYAH appears ready to respond to strict data security requirements, uses medical data in a HIPAA-compliant setting

Telehealth is becoming increasingly popular with patients and doctors alike, but securing the integrity of patient information remains critical. As a company developing proprietary technology supporting a data-driven healthcare approach, RYAH Group appears ready to respond to the strict data security requirements.

With patients needing more access to health care, and providers and payers looking to reduce health-care costs, the use of telehealth solutions is exploding. More and more medical staff and patients alike are embracing digital healthcare options as a replacement for in-person care. Although the pandemic fuels the recent surge, the overall growth is not likely to stop once the…

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group are available in the company’s newsroom at https://ibn.fm/RYAH

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork.

BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at Upcoming H.C. Wainwright Global Life Sciences Conference

March 4, 2021 13:16:04

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that the company’s CEO, John Climaco, will present at the virtual H.C. Wainwright Global Life Sciences Conference taking place March 9-10, 2021. According to the update, CNSP management will also be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the event. Interested parties should visit https://ibn.fm/XlGLZ for more information and to register for the conference.

To view the full press release, visit https://ibn.fm/D4QcN

About CNS Pharmaceuticals Inc.

CNS Pharmaceuticals is developing novel treatments for primary and metastatic cancers of the brain and central nervous system. Its lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. CNS holds a worldwide exclusive license to the Berubicin chemical compound and has acquired all data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase 1 clinical trial with Berubicin in malignant brain tumors, which Reata conducted in 2006. In this trial the overall response rate of stable disease or better was 44%. This 44% disease control rate was based on 11 patients (out of 25 evaluable patients) with stable disease, plus responders. One patient experienced a durable complete response and remains cancer-free as of Feb. 20, 2020. These Phase 1 results represent a limited patient sample size and, while promising, are not a guarantee that similar results will be achieved in subsequent trials. During 2021, CNS expects to commence a Phase 2 clinical trial of Berubicin for the treatment of GBM in the U.S., while a sub-licensee partner undertakes a Phase 2 trial in adults and a first-ever Phase 1 trial in pediatric GBM patients in Poland. Its second drug candidate, WP1244, is a novel DNA binding agent that has shown in preclinical studies that it is 500 times more potent than the chemotherapeutic agent daunorubicin in inhibiting tumor cell proliferation. For more information, visit the company’s website at www.CNSPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork

SRAX Inc.’s (NASDAQ: SRAX) Sequire Investor Analytics Platform Helps Public Companies Monitor Investors Amid Record-Breaking Microcap Trading Activity

March 4, 2021 12:48:21

Microcap stocks outperforming 2020 record highs, currently trading at 40% above 200-day moving average
SRAX’s Sequire SaaS platform provides public companies with tools to monitor trading activity, provides actionable insights for use in marketing campaigns
Sequire subscriber base surged to 3 million active traders across 90 public companies since its 2019 inception

Investor interest sent microcap stocks sky-high in 2020, a trend that is continuing well into 2021 with returns on some microcap ETFs surging at several times the rate of comparable large-cap ETFs (https://ibn.fm/Bu86D). As the tide of investor interest continues to flow into microcaps, public companies are leveraging the power of data through Sequire, SRAX’s (NASDAQ: SRAX) investor analytics SaaS platform that unlocks data and insights critical to targeted marketing campaigns in order to engage current traders and attract new investors.

Small caps – companies generally valued between $50 and $300 million – are typically thought to be more volatile and riskier when compared to established companies. Throughout 2020 and so far in 2021, that risk has paid off for investors willing to take a chance on new companies – particularly those included by SRAX subsidiary LD Micro in its North American microcap index which comprises nearly…

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

MiningNewsBreaks – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) Issues Rio Loa Drilling Update, Prepares for First Phase Drilling at Alicia

March 4, 2021 12:36:27

GoldHaven Resources (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS), a Canada-based company engaged in the business of acquiring and exploring mineral resource properties, today announced that Phase I drilling continues to advance as planned at Rio Loa. According to the update, the Rio Loa project is located 25 km south of Gold Field’s Salares Norte deposit (5.2 million ounces equivalent of gold scheduled to produce 450,000oz of gold per annum*) and 6 km south of Gold Field’s Horizonte discovery. The GoldHaven team is actively drilling hole RCRL-003, which is currently in argillic altered limonite-rich volcanic rocks. Silicified volcaniclastic rocks with incipient vuggy silica were intersected at various intervals to the current depth of 300 meters. RCRL-003 continues to be strongly oxidized with abundant disseminated limonite and is presently within a zone of silicification. “This is the right step in our development to unlock the potential of our 251 square km Maricunga district play,” said GoldHaven CEO Daniel Schieber. “The drilling continues as planned and has been providing us with what we want to see at this stage. The Alicia project is next-up for drilling, which will provide consistent news-flow after we complete at Rio Loa.”

To view the full press release, visit https://ibn.fm/3SKnm

About GoldHaven Resources Corp.

GoldHaven is a Canadian junior exploration company active in the Maricunga Gold Belt of northern Chile. The Maricunga Belt measures 150 km north-south and 30 km east-west and is host to numerous discoveries over the past twenty years and has a prolific gold, silver, copper metal endowment. The company has agreements in place to acquire seven high priority exploration targets, which were identified by geological studies. To date, GoldHaven considers four of these seven properties “high priority” targets and will commence drilling during the first quarter of 2021. The four priority targets include Coya, located approximately 16 km northeast of the La Coipa mine where Kinross announced a mining re-start in 2020; the second is Rio Loa, a project located 25 km south of Gold Field’s Salares Norte deposit (5.2 million ounces of gold equivalent); the third and fourth projects are Alicia and Roma, which are approximately 35 km. south of the Salares Norte deposit. These exploration targets have been designated high priority due to extensive, pervasive alteration, favourable geology, highly anomalous rock geochemical results, and their relative proximity to existing deposits. For more information about the company, visit www.GoldHavenResources.com.

*Jamasmie, C., 2019. Gold Field’s Salares Norte project in Chile granted environmental permit. December 18, 2019, 9:29am. Exploration Intelligence Latin America Gold Silver. https://www.mining.com/gold-fields-salares-norte-project-in-chile-granted-environmental-permit/

NOTE TO INVESTORS: The latest news and updates relating to GHVNF are available in the company’s newsroom at http://ibn.fm/GHVNF

About MiningNewsWire

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is part of the InvestorBrandNetwork.

Cybin Inc. (NEO: CYBN) (OTC: CLXPF) Newly Acquired Subsidiary Achieves Earn-Out Milestone —Successful Synthesis of Multiple Tryptamine Derivatives

March 4, 2021 12:18:13

Adelia Therapeutics has achieved earn-out milestones outlined in contribution agreement with Cybin
Adelia ideal acquisition for Cybin, as it leads innovation in researching psychedelic treatment options in the mental health space
Acquisition results in Cybin obtaining extensive intellectual property portfolio and product pipeline

Cybin (NEO: CYBN) (OTC: CLXPF), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, has announced that its recently acquired subsidiary, Adelia Therapeutics Inc., has achieved the earn-out milestones outlined for the time period in the contribution agreement between the two companies (https://ibn.fm/c6o2E). That milestone includes the successful synthesis of multiple tryptamine derivatives.

Furthermore, the synthesis of tryptamine derivatives resulted in quantities adequate enough that Adelia could initiate in vitro “Proof of Principle”; establish that an ADME/PK has been completed; and demonstrate “In Vitro” ADME “Proof of Principle” that specific synthesis modifies the…

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About PsychedelicNewsWire

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]

PsychedelicNewsWire is part of the InvestorBrandNetwork.

MiningNewsBreaks – Asia Broadband Inc. (AABB) Enters LOI to Acquire Mexico-Based Gold Mine and Production Facilities